Document:

exv4w4

Exhibit 4.4

AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT

Dated this 12th Day of August 2009

by and among

Xueersi International Education Group,

BRIGHT UNISON LIMITED,

CENTRAL GLORY INVESTMENTS LIMITED,

PERFECT WISDOM INTERNATIONAL LIMITED,

EXCELLENT NEW LIMITED,

KTB/UCI China Ventures II Limited,

TIGER GLOBAL FIVE CHINA HOLDINGS

and

CERTAIN ADDITIONAL PARTIES NAME HEREIN

 

 

SHAREHOLDERS’ AGREEMENT

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	1.

	 	DEFINITIONS AND INTERPRETATION
	 	 	3	 
	 
	 	 	 	 	 	 
	1.1

	 	DEFINITIONS.
	 	 	3	 
	 
	 	 	 	 	 	 
	1.2

	 	INTERPRETATION.
	 	 	8	 
	 
	 	 	 	 	 	 
	2.

	 	ORIGINAL SHAREHOLDERS’ AGREEMENT
	 	 	8	 
	 
	 	 	 	 	 	 
	3.

	 	DIVIDEND RIGHTS
	 	 	9	 
	 
	 	 	 	 	 	 
	4.

	 	BOARD SIZE AND COMPOSITION.
	 	 	9	 
	 
	 	 	 	 	 	 
	5.

	 	PROTECTIVE PROVISIONS
	 	 	9	 
	 
	 	 	 	 	 	 
	6.

	 	CONVERSION RIGHTS.
	 	 	11	 
	 
	 	 	 	 	 	 
	7.

	 	LIQUIDATION RIGHTS
	 	 	16	 
	 
	 	 	 	 	 	 
	8.

	 	INFORMATION AND INSPECTION RIGHTS
	 	 	16	 
	 
	 	 	 	 	 	 
	9.

	 	TAG ALONG RIGHTS
	 	 	17	 
	 
	 	 	 	 	 	 
	10.

	 	PREEMPTIVE RIGHTS
	 	 	18	 
	 
	 	 	 	 	 	 
	11.

	 	RIGHT OF FIRST REFUSAL, CO-SALE
	 	 	19	 
	 
	 	 	 	 	 	 
	12.

	 	REGISTRATION RIGHTS
	 	 	24	 
	 
	 	 	 	 	 	 
	13.

	 	REDEMPTION RIGHT
	 	 	33	 
	 
	 	 	 	 	 	 
	14.

	 	SHARE PREFERENCES; DOCUMNENT RELATIONS
	 	 	33	 
	 
	 	 	 	 	 	 
	15.

	 	NOTICE
	 	 	34	 
	 
	 	 	 	 	 	 
	16.

	 	MISCELLANEOUS
	 	 	34	 

SCHEDULE 1 PARTICULARS OF THE COMPANY AS AT THE DATE OF THIS AGREEMENT

 

 

AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT

THIS AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (this “Agreement”) is made on August 12, 2009 by
and among the following parties:

	 	(1)	 	Xueersi International Education Group (), a company organized
under the laws of Cayman Islands (the “Company”);
	 
	 	(2)	 	TAL Group Limited, a company organized under the laws of Hong Kong (the “HK
Company”);
	 
	 	(3)	 	TAL Education Technology (Beijing) Co., Ltd. (), a wholly
foreign-owned enterprise organized under the laws of the PRC (the “WFOE”);
	 
	 	(4)	 	Beijing Xueersi Education Technology Co., Ltd. (), a
company organized under the laws of the PRC (“Xueersi Education”);
	 
	 	(5)	 	Beijing Xueersi Network Technology Co., Ltd. (), a company
organized under the laws of the PRC (“Xueersi Technology”, together with Xueersi
Education, “Domestic Companies”);
	 
	 	 	 	Unless the context requires or provides otherwise, the Company, HK Company, the WFOE, the
Domestic Companies and their Subsidiaries (including schools and company branches under
direct or indirect control thereof) are hereinafter collectively referred to as “Group
Entities”, and each a “Group Entity”.
	 
	 	(6)	 	BRIGHT UNISON LIMITED, a company organized under the laws of BRITISH VIRGIN ISLAND;
	 
	 	(7)	 	CENTRAL GLORY INVESTMENTS LIMITED, a company organized under the laws of BRITISH
VIRGIN ISLAND;
	 
	 	(8)	 	PERFECT WISDOM INTERNATIONAL LIMITED, a company organized under the laws of BRITISH
VIRGIN ISLAND;
	 
	 	(9)	 	EXCELLENT NEW LIMITED a company organized under the laws of BRITISH VIRGIN ISLAND;
	 
	 	 	 	Unless the context requires or provides otherwise, BRIGHT UNISON LIMITED, CENTRAL GLORY
INVESTMENTS LIMITED, PERFECT WISDOM INTERNATIONAL LIMITED and EXCELLENT NEW LIMITED are
hereinafter collectively referred to as the “Sellers”, and each a “Seller”.
	 
	 	(10)	 	ZHANG Bangxin, a Chinese resident, with its PRC ID number of 321182198010012913
(“Zhang”);
	 
	 	(11)	 	CAO Yundong, a Chinese resident, with its PRC ID number of 372831197910205618
(“Cao”);
	 
	 	(12)	 	LIU Yachao, a Chinese resident, with its PRC ID number of 211103198110152138 (“Liu”);

1

 

	 	(13)	 	BAI Yunfeng, a Chinese resident, with its PRC ID number of 360521198109240073
(“Bai”);
	 
	 	 	 	Unless the context requires or provides otherwise, Zhang, Cao, Liu and Bai are
hereinafter collectively referred to as the “Founders”, and each a “Founder”.
	 
	 	(14)	 	KTB/UCI China Ventures II Limited, a limited liability company with its BVI Company
Number: 1039743 and registered address at Portcullis TrustNet (BVI) Limited of Portcullis
TrustNet Chambers, PO Box 3444, Road Town, Tortola, British Virgin Islands (“KTB” or
“Series A Preferred Shareholder”); and
	 
	 	(15)	 	TIGER GLOBAL FIVE CHINA HOLDINGS, a company organized under the laws of Mauritius
(“Tiger”).

The Company, the HK Company, the WFOE, the Domestic Companies, the Sellers, the Series A Preferred
Shareholders and Tiger may hereinafter, as appropriate, collectively be referred to as the
“Parties” and individually referred to as a “Party”.

WHEREAS:

	 	(1)	 	The Company is a company incorporated under the laws of the Cayman Islands, the
particulars of which as at the date hereof are set out in Schedule 1 hereof;
	 
	 	(2)	 	On February 12, 2009, the Company, Series A Preferred Shareholder, Founders, and
certain relevant parties entered into a shareholders’ agreement (the “Original
Shareholders’ Agreement”);
	 
	 	(3)	 	On May 18, 2009, each of Zhang Bangxin, Cao Yundong, Liu Yachao and Bai Yunfeng
entered into a Sale of Shares with BRIGHT UNISON LIMITED, CENTRAL GLORY INVESTMENTS
LIMITED, PERFECT WISDOM INTERNATIONAL LIMITED and EXCELLENT NEW LIMITED, respectively,
pursuant to which Sellers purchased all the shares held by the Founders in the Company
and assumed all the right and obligations of Founders in the Company;
	 
	 	(4)	 	On August 12, 2009, the Company, the Sellers, KTB CHINA OPTIMUM FUND, Tiger and
certain other parties entered into a share purchase agreement, pursuant to which Tiger
purchased certain number of Common Shares of the Company from the Sellers and KTB CHINA
OPTIMUM FUND was granted an option to purchase certain number of Common Shares from the
Sellers on a date no later than September 4, 2009 (the “Purchase Agreement”);
	 
	 	(5)	 	To induce KTB CHINA OPTIMUM FUND and Tiger to enter into the Purchase Agreement and
pursuant to Section 2.7 thereof, the Company, the Sellers, the Series A Preferred
Shareholder and Tiger hereby agree that this Agreement shall restate and amend the
Original Shareholders’ Agreement, and govern certain shareholder rights and other relevant
matters as set out in this Agreement.

NOW, THEREFORE, in consideration of the premises set forth above, the mutual promises and covenants
set forth herein and other good and valuable consideration, the Parties hereto hereby agree as
follows:

2

 

			
	1.	 	DEFINITIONS AND INTERPRETATION

	1.1	 	Definitions.

	 	 	 
	“Additional Transfer Notice”

	 	has the meaning set forth in
Section 11.1(c);
	 
	 	 
	“Affiliate”

	 	means, with respect to any specified Person, any other Person who or which, directly or
indirectly, controls, is controlled by, or is under common control with such specified
Person, including, without limitation, any partner, officer, director, member or employee of
such Person and any venture capital fund now or hereafter existing that is controlled by or
under common control with one or more general partners or managing members of, or shares the
same management company with, such Person;
	 
	 	 
	“Agreement”

	 	has the meaning set forth in the introductory paragraph;
	 
	 	 
	“Applicable Securities Law”

	 	means (i) with respect to any offering of securities in the United States of America, the
securities law of the United States, as amended from time to time, including the Exchange
Act and the Securities Act, and any applicable law of any state of the United States of
America, and (ii) with respect to any offering of securities in any jurisdiction other than
the United States of America, the applicable laws of that jurisdiction;
	 
	 	 
	“Articles”

	 	means the Articles of Association of the Company, as amended from time to time;
	 
	 	 
	“Board”

	 	means the board of directors for the time being of the Company;
	 
	 	 
	“Business Day”

	 	means any day, other than a Saturday, Sunday or other day on which the commercial banks in
Hong Kong and Beijing are authorized or required to be closed for the conduct of regular
banking business;
	 
	 	 
	“Closing”

	 	has the meaning set forth in the Series A Share Purchase Agreement;
	 
	 	 
	“Commission”

	 	means (i) with respect to any offering of securities in the United States of America, the
Securities and Exchange Commission of the United States or any other federal agency at the
time administering the Securities Act, and (ii) with respect to any offering of securities
in a jurisdiction other than the United States, the regulatory body of the jurisdiction with
authority to supervise and regulate the sale of securities in that jurisdiction;
	 
	 	 
	“Common Shares”

	 	means the Common Shares of the Company with par value of US$0.001 per share;

3

 

	 	 	 
	“Common Share Equivalents”

	 	means warrants, options and rights exercisable for Common Shares and instruments convertible
or exchangeable for Common Shares;
	 
	 	 
	“Company”

	 	has the meaning set forth in the introductory paragraph (1);
	 
	 	 
	“Conversion Price”

or “Applicable Conversion Price”

	 	has the meaning set forth in Section 6.3;
	 
	 	 
	“Co-sale Participant”

	 	has the meaning set forth in Section 11.2(a);
	 
	 	 
	“Domestic Companies”

	 	has the meaning set forth in the introductory paragraph (5);
	 
	 	 
	“Equity Securities”

	 	means any Common Shares or Common Share Equivalents;
	 
	 	 
	“Exchange Act”

	 	means United States Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder;
	 
	 	 
	“Founders”

	 	has the meaning set forth in Section the introductory paragraph (13);
	 
	 	 
	“Fully-Exercising Shareholder”

	 	has the meaning set forth in Section 10.2;
	 
	 	 
	“Fully Participating Shareholder”

	 	has the meaning set forth in Section 11.1(b);
	 
	 	 
	“Future Issuance Price”

	 	has the meaning set forth in Section 6.3(5)(a);
	 
	 	 
	“Group Entities”

	 	has the meaning set forth in the introductory paragraph (5);
	 
	 	 
	“Holders”

	 	means Tiger, KTB or any person to whom the shares of the Company held by any of them is
transferred;
	 
	 	 
	“Hong Kong”

	 	means the Hong Kong Special Administrative Region of the PRC;
	 
	 	 
	“HK Company”

	 	has the meaning set forth in the introductory paragraph (2);
	 
	 	 
	“HKIAC”

	 	has the meaning set forth in Section 16.8(c);
	 
	 	 
	“Initiating Holders”

	 	has the meaning set forth in Section 12.1(1);
	 
	 	 
	“IPO”

	 	means an initial public offering by the Company of its Common Shares on a public stock
exchange of the United States that has been registered under the Securities Act, or in a
similar public offering of Common Shares in a jurisdiction and on a recognized securities
exchange outside of the United States, provided such an initial public offering in terms of
price, offering proceeds and regulatory approval is reasonably equivalent to the aforesaid
public offering in the United States.

4

 

	 	 	 
	“Issuance Notice”

	 	has the meaning set forth in Section 10.1;
	 
	 	 
	“KTB”

	 	has the meaning set forth in the introductory paragraph (14);
	 
	 	 
	“Liquidation Event”

	 	has the meaning set forth in Section 7.1;
	 
	 	 
	“New Common Director”

	 	has the meaning set forth in Section 4(b);
	 
	 	 
	“New Common Shares”

	 	means the Common Shares acquired by Tiger and KTB CHINA OPTIMUM FUND, if any, from the
Sellers pursuant to the Purchase Agreement;
	 
	 	 
	“New Securities”

	 	means any Equity Securities of the Company; provided that the term “New Securities” does not
include (i) securities issued upon conversion of the Preferred Shares; (ii) securities
issued to employees, professional consultants, officers or directors of the Company pursuant
to any stock option, stock purchase or stock bonus plan, agreement or arrangement approved
by the Board; (iii) securities issued in a Qualified Public Offering; (iv) securities issued
in connection with any stock split, stock dividend or re-capitalization of the Company; and
(v) securities issued upon the exercise of that certain set forth in Section 6.6 of the
Purchase Agreement;
	 
	 	 
	“Non-selling Shareholder”

	 	has the meaning as set forth in Section 11.1(a);
	 
	 	 
	“Original Issue Price”

	 	means US$1.00 for each Series A Preferred Share, or the aggregate amount of issue price
based on such price per share;
	 
	 	 
	“Original Shareholders’ Agreement”

	 	has the meaning set forth in Recital (2);
	 
	 	 
	“Over-allotment Notice”

	 	has the meaning set forth in Section 11.1(b);
	 
	 	 
	“Over-allotment Shares”

	 	has the meaning set forth in Section 11.1(b);
	 
	 	 
	“Participating Shareholders”

	 	has the meaning set forth in Section 11.1(b);
	 
	 	 
	“Person”

	 	means any individual, person corporate, corporation, partnership, limited partnership,
proprietorship, association, limited liability company, firm, trust, estate or enterprise or
entity;
	 
	 	 
	“PRC”

	 	means the People’s Republic of China, for the purpose of this Agreement, excluding Hong
Kong, the Macau Special Administrative Region and Taiwan;
	 
	 	 
	“Preferred Shareholders”

	 	means all of Series A Preferred Shareholder;
	 
	 	 
	“Purchase Agreement”

	 	has the meaning set forth in Recital(3);

5

 

	 	 	 
	“Qualified Public Offering” or “Qualified IPO”

	 	means an initial public offering by the Company of its Common Shares on a public stock
exchange of the United States that has been registered under the Securities Act, with the
net proceeds to the Company of at least US$50,000,000 (excluding the underwriting discounts,
selling commissions and expenses) and an implied market capitalization of the Company of at
least US$300,000,000 or in a similar public offering of Common Shares in a jurisdiction and
on a recognized securities exchange outside of the United States, provided such initial
public offering in terms of price, offering proceeds and regulatory approval is reasonably
equivalent to the aforesaid public offering in the United States;
	 
	 	 
	“Registration” or “Registrations”

	 	means a registration or the registrations effected by preparing and filing a Registration
Statement and the declaration or ordering of the effectiveness of that Registration
Statement;
	 
	 	 
	“Registrable Securities”

	 	means any (i) Series A Preferred Shares and New Common Shares (ii) any shares issued as (or
issuable upon the conversion or exercise of any warrant, right or other security that is
issued) a dividend or other distribution with respect to, or in exchange for, or in
replacement of, the shares referenced in (i) above, excluding in all cases, however, any
Registrable Securities sold by a person in a transaction in which his, her or its rights
under Section 12 of this Agreement are not assigned;
	 
	 	 
	“Remaining Shares”

	 	has the meaning set forth in Section 11.1(c);
	 
	 	 
	“Restructuring”

	 	has the meaning set forth in Section 5.1(a);
	 
	 	 
	“Rule 144”

	 	means Rule 144 promulgated under the United States Securities Act of 1933, as such rule may
be amended from time to time, or any successor or substitute rule, law or provision;
	 
	 	 
	“Securities Act”

	 	means the United States Securities Act of 1933, as amended and the rules and regulations
promulgated thereunder;
	 
	 	 
	“Sellers”

	 	has the meaning set forth in Section the introductory paragraph (9);
	 
	 	 
	“Selling Expenses”

	 	means all underwriting discounts and selling commissions applicable to the sale of
Registrable Securities pursuant to this Agreement;
	 
	 	 
	“Selling Shareholders”

	 	has the meaning set forth in Section 9.1;
	 
	 	 
	“Series A Preferred Shares”
or “Preferred Shares”

	 	 

means the Company’s voting Series A Preferred Shares, with

6

 

	 	 	 
	 

	 	par value of US$0.001 each with the rights and privileges
as set forth in this Agreement and the Articles;
	 
	 	 
	“Series A Preferred Shareholders”

	 	has the meaning set forth in the introductory paragraph (10);
	 
	 	 
	“Series A Share Purchase Agreement”

	 	means the certain share purchase agreement dated February 12, 2009 by and among the same
parties to the Original Shareholders’ Agreement in connection with the subscription of
Series A Preferred Shares by KTB.
	 
	 	 
	“Share”

	 	means a share or, where applicable, Share Equivalent (on as-converted basis) in the share
capital of the Company (of whatever class);
	 
	 	 
	“Share Offered by Shareholder”

	 	has the meaning set forth in Section 11.1(a);
	 
	 	 
	“Shareholder”

	 	means a holder of Shares from time to time or its lawful successor;
	 
	 	 
	“Subsidiary(ies)” or “subsidiary”

	 	means as of the relevant date of determination, with respect to any Person (the “subject
entity”), (i) any Person: (1) more than 50% of whose shares or other interests entitled to
vote in the election of directors or (2) more than a fifty percent (50%) interest in the
profits or capital of such Person are owned or controlled directly or indirectly by the
subject entity or through one (1) or more Subsidiaries of the subject entity, (ii) any
Person whose assets, or portions thereof, are consolidated with the net earnings of the
subject entity and are recorded on the books of the subject entity for financial reporting
purposes in accordance with US GAAP (or other standard acceptable to the Series A Preferred
Shareholders and Tiger), or (iii) any Person with respect to which the subject entity has
the power to otherwise direct the business and policies of that entity directly or
indirectly through another subsidiary. For the avoidance of doubt, the Subsidiaries of the
Company shall include the Group Entities.
	 
	 	 
	“Tiger”

	 	means Tiger Global Five China Holdings, a company organized under the laws of Mauritius,
and its Affiliates or any of its (or their) successor(s).
	 
	 	 
	“Transfer”

	 	has the meaning set forth in Section 11.1(a);
	 
	 	 
	“Transfer Notice”

	 	has the meaning set forth in Section 11.1(a);
	 
	 	 
	“Transferor”

	 	has the meaning set forth in Section 11.1(a);
	 
	 	 
	“Violation”

	 	has the meaning set forth in Section 12.4(1) (a);
	 
	 	 
	“WFOE”

	 	has the meaning set forth in the introductory paragraph (3);

7

 

	 	 	 
	“Xueersi Education”

	 	has the meaning set forth in the introductory paragraph (4); and
	 
	 	 
	“Xueersi Technology”

	 	has the meaning set forth in the introductory paragraph (5);

	1.2	 	Interpretation.

For all purposes of this Agreement, except as otherwise expressly provided:

	 	(a)	 	the terms defined in this Section 1 shall have the meanings assigned to them
in this Section 1 and include the plural as well as the singular;
	 
	 	(b)	 	references to a Shareholder shall include references to his successors or permitted
assignees;
	 
	 	(c)	 	all accounting terms not otherwise defined herein have the meanings assigned under
IAS;
	 
	 	(d)	 	all references in this Agreement to designated “Sections” and other subdivisions are
to the designated Sections and other subdivisions of the body of this Agreement;
	 
	 	(e)	 	pronouns of either gender or neuter shall include, as appropriate, the other pronoun
forms;
	 
	 	(f)	 	the words “herein”, “hereof” and “hereunder” and other words of similar import refer
to this Agreement as a whole and not to any particular Section or other subdivision; and
	 
	 	(g)	 	all references in this Agreement to designated schedules, exhibits and annexes are to
the Schedules, Exhibits and Annexes attached to this Agreement unless explicitly stated
otherwise.

			
	2.	 	ORIGINAL SHAREHOLDERS’ AGREEMENT

	2.1	 	Each of the parties to the Original Shareholders’ Agreement hereby agrees that the Original
Shareholders’ Agreement (including any and all of its rights, privileged and benefits as
endowed thereby) shall be terminated and replaced in its entirety by this Agreement effective
from and as of the date hereof. Without limitation to the foregoing, the Series A Preferred
Shareholder hereby irrevocably and unconditionally waives its rights under Section 10
of the Original Shareholders’ Agreement and Articles 129 through 131 of the Company’s first
amended and restated articles of association, dated February 12, 2009, in connection with the
acquisition of Common Shares by Tiger and KTB from the Sellers pursuant to the Purchase
Agreement.
	 
	2.2	 	Each of the parties to the Original Shareholders’ Agreement hereby irrevocably and
unconditionally waives any and all of its rights, as endowed by the Original Shareholders’
Agreement, to initiate any claim, demand, dispute, obligation, liability and issue, contingent
or otherwise which it has, or may in the future have, against the other parties arising out of
or in connection with the Original Shareholders’ Agreement.

8

 

			
	3.	 	DIVIDEND RIGHTS

	3.1	 	Dividend Rights. Subject to the circumstances prevailing at the relevant time including, in
particular, the working capital requirements of the Company, the Company may distribute by way
of dividend in accordance with the Articles in respect of each financial year such of its
profits as are then lawfully available for distribution as subject to the discretion of the
Board. The dividend shall be distributed among the Common Shareholders and Holders ratably
according to the number of Common Shares each Preferred Share may be converted into. Dividends
shall be non-cumulative.

			
	4.	 	BOARD SIZE AND COMPOSITION.

     The Board of the Company shall consist of up to five (5) Directors, whose nomination and
election shall be as follows:

	 	(a)	 	The holders of majority of Common Shares (excluding Common Shares held by Tiger
and KTB CHINA OPTIMUM FUND, if any), shall be entitled to, by written notice to the
Company, nominate and elect one (1) Director to the Board, initially to be ZHANG
Bangxin, and shall also be entitled to remove any such Director occupying such position
and to fill any vacancy caused by the resignation, death or renewal of any such
Director occupying such position;
	 
	 	(b)	 	Tiger shall be entitled to, by written notice to the Company, nominate and
elect one (1) Director to the Board, initially to be CHEN Xiaohong (“New Common
Director”), and shall also be entitled to remove any such Director occupying such
position and to fill any vacancy caused by the resignation, death or renewal of any
such Director occupying such position.
	 
	 	(c)	 	The Series A Preferred Shareholder shall be entitled to, by written notice to
the Company, nominate and elect one (1) Director to the Board, initially to be YEH
Aieming Amy (“Series A Director”), and shall also be entitled to remove any such
Director occupying such position and to fill any vacancy caused by the resignation,
death or renewal of any such Director occupying such position.
	 
	 	(d)	 	Any Shareholder may nominate a Director to fill the remaining two (2)
directors; provided that the election of such Director(s) shall be subject to the
approval of all of the Shareholders voting together as a single class on an
as-converted basis.

     The chairman of the Board (“Chairman of the Board”) shall be elected by the Board with
majority votes.

			
	5.	 	Protective Provisions

	5.1	 	Veto Rights of KTB. Subject to Section 5.2 below, so long as there are any
Series A Preferred Shares outstanding, the Company shall not take, and shall procure that each
Group Entity does not take, whether in one transaction or through a series of transactions, or
whether by amending the Articles or otherwise, any of the following actions without (i) the
prior written consent of the holders of majority of the outstanding Series A Preferred Shares;
or (ii) the prior consent of the Board, including the affirmative consent of the Series A
Director, and in the context of such matters set forth in this Section 5.1 which are
by applicable laws required to be determined by the shareholders of the Company, the approval
of the holders of at least a majority of the then

9

 

	 	 	outstanding Series A Preferred Shares shall be deemed obtained if the matter is approved at
a general meeting of the Company with the affirmative vote of the holders of at least a
majority of the then outstanding Series A Preferred Shares or by way of written resolution
signed by all the holders of the outstanding Series A Preferred Shares:

	 	(a)	 	dissolve or liquidate any Group Entity (other than as a result of the
restructuring of the Company’s Subsidiaries pursuant to a restructuring plan prior to
the IPO that is approved by the Board) (the “Restructuring”);
	 
	 	(b)	 	amend any of the charter/constitutional documents of any Group Entity or any of
its Subsidiaries that may affect the rights, preferences or privileges of KTB;
	 
	 	(c)	 	make changes in the capital structure of any Group Entity or any of its
Subsidiaries, including the creation or issuance of additional securities or securities
convertible or exchangeable into equity of the Company (other than as a result of the
Restructuring and/or a new round financing of the Company, as long as the pre-money
valuation of the Company in the new round financing reaches either (x) within 12 months
following Closing is at least 1.3 times of the post-money valuation of the Company in
the Series A financing on a fully diluted basis or (y) after 12 months following
Closing is at least 1.5 times of the post-money valuation of the Company in the Series
A financing on a fully diluted basis, and in any case of (x) or (y), the rights of KTB
shall rank at least pari passu with, and shall not be inferior to, the rights of the
new round investor(s).);
	 
	 	(d)	 	make or result in mergers, amalgamations, investments, acquisitions, joint
ventures and dispositions involving any Group Entity (other than as a result of the
Restructuring);
	 
	 	(e)	 	repurchase or redeem any shares, provided, however that this restriction shall
not apply to the repurchase of shares from employees, officers, directors, consultants
or other persons performing services for the Group Entity or any of its Subsidiaries
pursuant to agreements under which the Group Entity has the option to
repurchase such shares upon the occurrence of certain events, such as the termination of employment or
service;
	 
	 	(f)	 	make material changes to the scope, nature and/or activities of the business of
any Group Entity and its Subsidiaries;
	 
	 	(g)	 	approve or amend any annual operating and capital budgets and annual business
plan of any Group Entity;
	 
	 	(h)	 	make changes in the number of members of the board of any Group Entity or its
Subsidiaries where there is Director nominated by KTB sitting in such board;
	 
	 	(i)	 	adopt any new employee stock option plan and formation of the compensation
committee; and transactions with a related party; or
	 
	 	(j)	 	make any dividend or distributions on shares of any Group Entity.

	5.2	 	Veto Rights of Tiger. In addition to Section 5.1 above, the Company shall
not take, and shall procure that each Group Entity does not take, whether in one transaction
or through a series of transactions, or whether by amending the Articles or otherwise, the
following actions without the prior written consent of Tiger, and in the context of such
matters set forth in this Section 5.2 which are by applicable laws required to be
determined by the shareholders of the Company, the

10

 

	 	 	approval of Tiger shall be deemed obtained if the matter is approved at a general meeting
of the Company with the affirmative vote of Tiger or by way of written resolution signed by
Tiger:

	 	(a)	 	actions listed in Section 5.1(e) of this Agreement, provided that (i)
KTB’s exercise of its redemption rights in accordance with Section 13 of this
Agreement, or (ii) the Company’s exercise of its right of first refusal in accordance
with Section 11.1 of this Agreement shall not be subject to the veto rights of
Tiger set out herein;
	 
	 	(b)	 	enter into, or obligate itself to enter into, any related party transaction
with an Affiliate of the Company or any Subsidiary of the Company or any employee,
officer, director, administrator or shareholder of the Company or any Subsidiary of the
Company or any member of such person’s immediate family, or any corporation,
partnership or other entity in which such person or family member is an officer,
director, administrator or partner, or in which such person or family member has
ownership or economic interests or otherwise controls such entity; or
	 
	 	(c)	 	alter or change, either by means of amending the Group Entity’s constitutional
documents or otherwise, the rights, preferences or privileges of Tiger.

	5.3	 	Matters Requiring Holders’ Presence and Vote.
	 
	 	 	So long as there are any Series A Preferred Shares outstanding, in
addition to any other vote or consent required elsewhere in this
Agreement, matters listed below shall be discussed in the
shareholders’ meeting with the presence of the Series A Preferred
Shareholder:

	 	(a)	 	incurrence of any debt, guarantees or liens in excess of RMB5,000,000 in the
aggregate (excluding any extension, renewal or refinancing of debt, guarantees or
liens outstanding at the Closing (as defined in the Series A Share Purchase Agreement)
on comparable or better terms);
	 
	 	(b)	 	appoint and/or reappoint a corporate auditor or changes in the accounting
principles of the Group Entity;
	 
	 	(c)	 	assignment and/or transfer by any Seller of the Equity Securities of the
Company and/or transfer by any Founder of the shares of the Sellers;
	 
	 	(d)	 	appoint and/or reappoint the chief executive officer or the chief financial
officer of the Company; or
	 
	 	(e)	 	any capital expenditures in excess of RMB1 million outside of budget approved
by the Board.

			
	6.	 	Conversion Rights.

	 	 	The Series A Preferred Shareholder shall have the following rights described below with
respect to the conversion of the Series A Preferred Shares into Common Shares: The number of
Common Shares to which the Series A Preferred Shareholder shall be entitled upon conversion
of any Series A Preferred Share shall be the quotient of the Original Issue Price over the
Conversion Price. For the avoidance of doubt, the initial conversion ratio for Series A
Preferred Shares to Common Shares shall be 1:1, subject to adjustments of the Conversion
Price as set forth below.

11

 

	6.1	 	Optional Conversion.

	 	(1)	 	Subject to and in compliance with the provisions of this Section 6, any
Preferred Shares may, at the option of the Holder, be converted at any time into
fully-paid and non-assessable Common Shares pursuant to Section 6.1(2) below.
Upon such conversion, all preference rights attached to such Series A Preferred Share
shall be automatically terminated.
	 
	 	(2)	 	The Series A Preferred Shareholder who desires to convert such Series A Preferred
Shares into Common Shares shall surrender the certificate therefore, duly endorsed, at
the office of the Company or any transfer agent for the Series A Preferred Shares, and
shall give written notice to the Company at such office that the Holder has elected to
convert such Shares. Such notice shall state the number of Series A Preferred Shares
being converted. Thereupon, the Company shall promptly issue and deliver to the Holder
at such office a certificate for the number of Common Shares to which such Holder is
entitled and shall promptly pay (i) in cash, any declared and unpaid dividends on the
Series A Preferred Shares being converted and (ii) in cash, the value of any fractional
Common Shares to which the Series A Preferred Shareholder would otherwise be entitled.
Such conversion shall be deemed to have been made at the close of business on the date
of the surrender of the certificates representing the Series A Preferred Shares to be
converted, and the person entitled to receive the Common Shares issuable upon such
conversion shall be treated for all purposes as the record holder of such Common Shares
on such date.

	6.2	 	Automatic Conversion.

	 	(1)	 	Without any action being required by the holder of such Series A Preferred Shares
and whether or not the certificates representing such Series A Preferred Shares are
surrendered to the Company or its transfer agent, each Series A Preferred Share shall
automatically be converted, based on the then-effective Conversion Price, immediately
upon the closing of the Qualified Public Offering.
	 
	 	(2)	 	The Company shall not be obligated to issue certificates for any Common Shares
issuable upon the automatic conversion of any Series A Preferred Shares unless the
certificate evidencing such Series A Preferred Shares is either delivered as provided
below to the Company or any transfer agent for the Series A Preferred Shares, or the
Series A Preferred Shareholder notifies the Company or its transfer agent that such
certificate has been lost, stolen or destroyed and executes an agreement satisfactory to
the Company to indemnify the Company from any loss incurred by it in connection with
such certificate. The Company shall, as soon as practicable after receipt of certificate
for Preferred Shares, or satisfactory agreement for indemnification in the case of a
lost certificate, promptly issue and deliver at its office to the Series A Preferred
Shareholder thereof a certificate or certificates for the number of Common Shares to
which such Series A Preferred Shareholder is entitled and shall promptly pay (i) in
cash, any declared and unpaid dividends on the Series A Preferred Shares being converted
and (ii) in cash, the value of any fractional Common Shares to which the Series A
Preferred Shareholder would otherwise be entitled. Any person entitled to receive Common
Shares issuable upon the automatic conversion of the Series A Preferred Shares shall be
treated for all purposes as the record holder of such Common Shares on the date of such
conversion.

	6.3	 	Conversion Price.

12

 

	 	 	The Conversion Price for the Series A Preferred Shares (“Conversion Price”) shall initially
equal to the Original Issue Price and shall be adjusted from time to time as provided below:

	 	(1)	 	Adjustment for Share Splits and Combinations. If the Company shall at any time,
or from time to time, effect a subdivision of the outstanding Common Shares, the
Conversion Price in effect immediately prior to such subdivision shall be
proportionately decreased. Conversely, if the Company shall at any time, or from time to
time, combine the outstanding Common Shares into a smaller number of shares, the
Conversion Price in effect immediately prior to the combination shall be proportionately
increased. Any adjustment under this paragraph shall become effective at the close of
business on the date the subdivision or combination becomes effective.
	 
	 	(2)	 	Adjustment for Common Share Dividends and Distributions. If the Company at any
time, or from time to time, makes (or fixes a record date for the determination of
holders of Common Shares entitled to receive) a dividend or other distribution to the
holders of Common Shares payable in Common Shares, in each such event the Conversion
Price then in effect shall be decreased as of the time of such issuance (or in the event
such record date is fixed, as of the close of business on such record date) by
multiplying the Conversion Price then in effect by a fraction (i) the numerator of which
is the total number of Common Shares issued and outstanding immediately prior to the
time of such issuance or the close of business on such record date, and (ii) the
denominator of which is the total number of Common Shares issued and outstanding
immediately prior to the time of such issuance or the close of business on such record
date plus the number of Common Shares issuable in payment of such dividend or
distribution.
	 
	 	(3)	 	Adjustments for Other Dividends. If the Company at any time, or from time to
time, makes (or fixes a record date for the determination of holders of Common Shares
entitled to receive) a dividend or other distribution payable in securities of the
Company other than Common Shares or Common Shares Equivalents, then, and in each such
event, provision shall be made so that, upon conversion of any Preferred Share
thereafter, the Series A Preferred Shareholder thereof shall receive, in addition to the
number of Common Shares issuable thereon, the amount of securities of the Company which
the Series A Preferred Shareholders would have received had the Series A Preferred Share
been converted into Common Shares immediately prior to such event, all subject to
further adjustment as provided herein.
	 
	 	(4)	 	Reorganizations, Mergers, Consolidations, Reclassifications, Exchanges,
Substitutions. If at any time, or from time to time, any capital reorganization or
reclassification of the Common Shares (other than as a result of a share dividend,
subdivision, split or combination otherwise treated above) occurs or the Company is
consolidated, merged or reorganized with or into another Person (other than a
consolidation, merger or reorganization treated in Section 6.1), then in any
such event, provision shall be made so that, upon conversion of any Preferred Share
thereafter, the Series A Preferred Shareholder thereof shall receive the kind and amount
of shares and other securities and property which the Series A Preferred Shareholder of
such share would have received had the Series A Preferred Share been converted into
Common Shares on the date of such event, all subject to further adjustment as provided
herein, or with respect to such other securities or property, in accordance with any
terms applicable thereto.
	 
	 	(5)	 	Sale of Shares below the Conversion Price.

13

 

	 	(a)	 	Adjustment of Series A Conversion Price Upon Issuance of Additional
Equity Securities. If at any time, or from time to time, the Company shall issue
or sell New Securities (other than (i) as a subdivision or combination of Common
Shares provided for in Section 6.3 (1) above, (ii) as a dividend or other
distribution provided for in Section 6.3 (2) above, (iii) the issuance of
Shares under any stock option plan, (iv) the conversion of Preferred Shares into
Common Shares, or (v) the issuance of New Securities in a Qualified Public
Offering) for a consideration of price per share (the “Future Issuance Price”)
less than the Series A Conversion Price, then, and in each such case, the
Conversion Price shall be reduced, as of the opening of business on the date of
such issue or sale, to equal such Future Issuance Price.
	 
	 	(b)	 	Determination of Consideration. For the purpose of making any
adjustment in the Conversion Price or number of Common Shares issuable upon
conversion of the Series A Preferred Shares, as provided above:

	 	(i)	 	To the extent it consists of cash, the consideration
received by the Company for any issue or sale of securities shall be
computed at the net amount of cash received by the Company after deduction
of any expenses payable directly or indirectly by the Company and any
underwriting or similar commissions, compensations, discounts or
concessions paid or allowed by the Company in connection with such issue or
sale;
	 
	 	(ii)	 	To the extent it consists of property other than cash,
consideration other than cash received by the Company for any issue or sale
of securities shall be computed at the fair market value thereof, as
determined in good faith by the Board as of the date of the adoption of the
resolution specifically authorizing such issue or sale, irrespective of any
accounting treatment of such property; and
	 
	 	(iii)	 	If New Securities or Common Share Equivalents
exercisable, convertible or exchangeable for New Securities are issued or
sold together with other stock or securities or other assets of the Company
for consideration which covers both, the consideration received for the New
Securities or Common Share Equivalents shall be computed as that portion of
the consideration received which is reasonably determined in good faith by
the Board to be allocable to such New Securities or Common Share
Equivalents.

	 	(c)	 	No Exercise. If all of the rights to exercise, convert or exchange
any Common Share Equivalents shall expire without any of such rights having been
exercised, the Series A Conversion Price as adjusted upon the issuance of such
Common Share Equivalents shall be readjusted to the Series A Conversion Price
which would have been in effect had no such adjustment been made.

	 	(6)	 	Certificate of Adjustment. In the case of any adjustment or readjustment of the
Conversion Price, the Company, at its sole expense, shall compute such adjustment or
readjustment in accordance with the provisions hereof and prepare a certificate showing
such adjustment or readjustment, and shall mail such certificate, by first class mail,
postage prepaid, to each registered Series A Preferred Shareholder at the holder’s
address as shown in the Company’s books. The certificate shall set forth such adjustment
or readjustment, showing in detail the facts upon which such adjustment or readjustment
is based, including a statement of (i) the consideration received or deemed to be
received by the Company for

14

 

	 	 	 	any New Securities issued or sold or deemed to have been issued or sold, (ii) the
number of New Securities issued or sold or deemed to be issued or sold, (iii) the
Conversion Price in effect after such adjustment or readjustment, and (iv) the number
of Common Shares and the type and amount, if any, of other property which would be
received upon conversion of the Preferred Shares after such adjustment or
readjustment.
	 
	 	(7)	 	Notice of Record Date. In the event the Company shall propose to take any action
of the type or types requiring an adjustment to the Conversion Price or the number or
character of the Series A Preferred Shares as set forth herein, the Company shall give
notice to the Series A Preferred Shareholder, which notice shall specify the record
date, if any, with respect to any such action and the date on which such action is to
take place. Such notice shall also set forth such facts with respect thereto as shall be
reasonably necessary to indicate the effect of such action (to the extent such effect
may be known at the date of such notice) on the Conversion Price and the number, kind or
class of shares or other securities or property which shall be deliverable upon the
occurrence of such action of deliverable upon the conversion of Series A Preferred
Shares. In the case of any action which would require the fixing of a record date, such
notice shall be given at least twenty (20) days prior to the date so fixed, and in the
case of all other actions, such notice shall be given at least thirty (30) days prior to
the taking of such proposed action.

	6.4	 	Fractional Shares. No fractional Common Shares shall be issued upon conversion of
any Preferred Share. All Common Shares (including fractions thereof) issuable upon conversion
of more than one Preferred Share by the Series A Preferred Shareholder thereof shall be
aggregated for purposes of determining whether the conversion would result in the issuance of
any fractional share. If, after such aggregation, the conversion would result in the issuance
of any fractional share, the Company shall round this fractional share up to 1 Share.
	 
	6.5	 	Reservation of Shares Issuable Upon Conversion. The Company shall at all times
reserve and keep available out of its authorized but un-issued Common Shares, solely for the
purpose of effecting the conversion of the Series A Preferred Shares. Such number of its
Common Shares as shall from time to time be sufficient to effect the conversion of all
outstanding Series A Preferred Shares. If at any time the number of authorized but un-issued
Common Shares shall not be sufficient to effect the conversion of all then outstanding Series
A Preferred Shares, the Company will take such corporate action as may, in the opinion of its
counsel, be necessary to increase its authorized but un-issued Common Shares to such number of
Shares as shall be sufficient for such purpose.
	 
	6.6	 	Notices. Any notice required by the provisions of this Section 6 shall be in
writing and shall be deemed effectively given: (i) upon personal delivery to the party to be
notified, (ii) when sent by confirmed telex or facsimile if sent during normal business hours
of the recipient; if not, then on the next business day, (iii) five (5) days after having been
sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. All notices shall be addressed to the Series A
Preferred Shareholder of record at the address of the Series A Preferred Shareholder appearing
on the books of the Company.
	 
	6.7	 	Payment of Taxes. The Company will pay all taxes (other than taxes based upon
income) and other governmental charges that may be imposed with respect to the issue or
delivery of Common Shares upon conversion of Series A Preferred Shares, excluding any tax or
other charge imposed in connection with any transfer involved in the issuance and delivery of
Common Shares in a name other than that in which the Series A Preferred Shares so converted
were registered.

15

 

			
	7.	 	LIQUIDATION RIGHTS

	7.1	 	Liquidation Event. The following events shall be treated as a liquidation,
dissolution or winding up (each, a “Liquidation Event”) unless waived by the holders of at
least fifty-one percent (51%) of the then outstanding Series A Preferred Shares, voting
together as a single class on an as-converted basis:

	 	(i)	 	any consolidation or merger of the Company with or into any
Person, or any other corporate reorganization, including a sale or acquisition
of equity securities of the Company, in which the Shareholders of the Company
immediately before such transaction own less than 50% of the Company’s voting
power immediately after such transaction (excluding any transaction effected
solely for tax purposes or to change the Company’s domicile);
	 
	 	(ii)	 	a sale of all or substantially all of the assets of the
Company; or
	 
	 	(iii)	 	any termination, liquidation, dissolution or winding up of the
Company;

	 	 	and upon any such event, any proceeds generated therefrom to which the Shareholders of the
Company are entitled to shall be distributed in accordance with the terms of Section
7.2.
	 
	7.2	 	Liquidation Preferences. Upon any Liquidation Event, whether voluntary or
involuntary, unless any Preferred Shareholder has agreed otherwise in advance and in writing
on the definitive liquidation plan of the Company,

	 	(i)	 	Before any distribution or payment shall be made to the holders
of any Common Shares, the holder of Series A Preferred Shares shall be entitled
to receive an amount equal to one hundred percent (100%) of the Original Issue
Price (adjusted for any share splits, share dividends, combinations,
recapitalizations and similar transactions), plus any declared but unpaid
dividends with respect thereto (as adjusted for any share splits, share
dividends, combinations, recapitalizations and similar transactions) per Series
A Preferred Share then held by such holder. All arrears or accruals of
dividends as declared by the Board due to the holders of Series A Preferred
Shares are in priority to the holders of all other shares.
	 
	 	(ii)	 	After distribution or payment in full of the amount
distributable or payable on the Series A Preferred Shares pursuant to
Section 7.2(i) of this Agreement, the remaining assets of the Company
available for distribution to Shareholders shall be distributed ratably among
the then holders of outstanding Common Shares and holders of Series A Preferred
Shares on an as-converted basis.

			
	8.	 	INFORMATION AND INSPECTION RIGHTS

	8.1	 	Delivery of Financial Statements. The Company shall deliver to each of the Holders:

	 	(a)	 	within ninety (90) days after the end of each fiscal year of the Company, annual
consolidated financial statements of the Company for such fiscal year, all prepared in
accordance with US GAAP (or other standard acceptable to the Holders), and audited and
certified by independent certified public accountants of recognized international
standing

16

 

	 	 	 	and reputation selected by the Company and approved by the Board;
	 
	 	(b)	 	within thirty (30) days of the end of each quarter, unaudited consolidated
financial statements for such quarter for the Company; and
	 
	 	(c)	 	at least forty-five (45) days prior to the end of each fiscal year, an annual
consolidated budget for the succeeding fiscal year, including without limitation, for
each month during such succeeding fiscal year projected balance sheets, income
statements and statements of cash flows.

	8.2	 	Financial Statements. For the purpose of this Section 8, the term “financial
statements” shall be construed to include a balance sheet, statement of earnings, stockholders
equity and cash flows for the applicable period, prepared in accordance with US GAAP (or other
standard acceptable to the Holders) and compared against the Company’s annual operating plan
and budget.
	 
	8.3	 	Inspection. The Company shall permit each Holder, as the same as any other
Shareholders, to visit and inspect the properties and examine the books of account and records
as deemed by the Holders to be material to the Company’s performance and outlook of the
Company and discuss the affairs, finances and accounts of the Company with the directors,
officers, employees, accountants, legal counsel and investment bankers of the Company, all at
such reasonable times as notified by the Holders.
	 
	8.4	 	Termination of Information and Inspection Covenants. The covenants set forth in
Sections 8.1 to 8.3 shall terminate as to any Holder and be of no further
force or effect upon the earlier of (i) immediately prior to the closing of a Qualified Public
Offering, (ii) the date when the Company first becomes subject to the periodic reporting
requirements of Sections 12(g) or 15(d) of the Exchange Act (or comparable requirements under
the laws of another jurisdiction), and (iii) such date as the Holder holds no shares in the
Company.
	 
	8.5	 	Assignment. The rights of any Holder under this Section 8 shall only be
assigned (i) to another Holder, (ii) to an Affiliate of such Holder which acquires any of the
Equity Securities thereof, or (iii) to an assignee or transferee who acquires any of the
Equity Securities thereof.

			
	9.	 	TAG ALONG RIGHTS

	9.1	 	Tag Along Rights. Without prejudice to any right and privilege of Series A Preferred
Shareholder and Tiger provided under Section 11.2 of this Agreement, if at any time
the majority of Sellers propose to, by the way of assignment or transfer, transfer Equity
Securities or any Common Shareholder(s) proposes to transfer or assign Equity Securities
representing 50% or more voting power in the Company to one or more third parties (“Selling
Shareholders”, each a “Selling Shareholder”) pursuant to an understanding with such third
parties in bona fide and good faith, and based on a pre-money valuation of the Company which
is at least US$250 million, such Selling Shareholder shall give each of the Holders and the
Company written notice of its intention to make the transfer, which shall include (i) a
description of the Equity Securities to be transferred, (ii) the identity of the prospective
transferee of the Common Shares, and (iii) the consideration and the material terms and
conditions upon which such Common Shares are to be transferred or assigned, and attached with
a copy of any written proposal, term sheet or letter of intent or other agreement relating to
the proposed transfer. The Transfer Notice shall be evidence that such Selling Shareholder has
received a firm offer from the prospective transferee and in good faith believes that a
binding agreement for the transfer is obtainable on terms set forth in the notice.

17

 

	9.2	 	Option to Transfer the Shares of the Remaining Shareholders. Upon the receipt of the
written notice of the Selling Shareholder pursuant to Section 9.1 above, the Holders
shall have the option to require their Shares of the Company to be sold to the transferee on
the same terms and conditions as set forth in such written notice. To exercise the option,
the Holders shall give the Selling Shareholders of the Company and the Company written notice
to such effect. Upon the receipt of such notice, the Selling Shareholders shall have the
obligation to sell the respective shares of the Holders on the same terms and conditions with
the sale of the Common Shares of the Company.
	 
	9.3	 	Termination of the Rights of Tag Along Right. The right of tag along provided under
this Section 9 shall be terminated immediately prior to the closing of a Qualified
Public Offering.

			
	10.	 	PREEMPTIVE RIGHTS

	10.1	 	Right of First Offer. Subject to the terms and conditions specified in this Section
10, each time the Company proposes to issue any New Securities, the Company shall first offer
such New Securities to each of the Holders in a written notice (an “Issuance Notice”) setting
forth (i) a description of the New Securities to be issued, including the rights and powers
associated therewith, and (ii) the number of such New Securities to be offered, and (iii) the
price and terms upon which it proposes to offer the New Securities.
	 
	10.2	 	Exercise of Preemptive Rights. By written notification received by the Company
within twenty-one (21) calendar days after delivery of the Issuance Notice to the Holders,
such Holders may elect to purchase, at the price and on the terms specified in the Issuance
Notice, up to such portion of the New Securities offered as equal to the proportion that the
number of Common Shares (including shares of Common Shares issuable upon conversion, exchange
or exercise of Common Shares Equivalents) then held by such Holder bears to the total number
of shares of Common Shares then outstanding (determined on a fully-diluted basis, assuming the
exercise, conversion or exchange of any Common Shares Equivalents). The Company shall
promptly, in writing, inform the Holders that elect to purchase all the New Securities
available to it pursuant to this Section 10.2 (a “Fully-Exercising Shareholder”) of
any other Holders’ failure to do likewise. During the ten (10) day period commencing after
such information is given, the Fully-Exercising Shareholder may elect to purchase a pro rata
share of any New Securities unsubscribed by the Holders, pursuant to its rights hereunder,
that is equal to the proportion that the number of Common Shares (including shares of Common
Shares issuable upon conversion, exchange or exercise of Common Shares Equivalents) then held
by the Fully-Exercising Shareholder bears to the total number of Common Shares then
outstanding (determined on a fully-diluted basis, assuming the exercise, conversion or
exchange of any Common Shares Equivalents).
	 
	10.3	 	Issuance of Unsubscribed New Securities. Upon expiration of the period described in
Section 10.2 hereof, unsubscribed New Securities may be offered by the Company during
the one hundred and twenty (120) day period thereafter to any person or persons at a price not
less, and upon terms no more favourable to the offeree, than specified in the Issuance Notice.
If the Company does not enter into an agreement for the sale of the unsubscribed New
Securities within such 120-day period, or if such agreement is not consummated within
forty-five (45) days of the execution thereof, the pre-emptive rights of the Holders under
this Section 10 shall be deemed revived and such unsubscribed New Securities shall not
be offered unless first re-offered to the Holders in accordance herewith.
	 
	10.4	 	Exempted Issuance. Notwithstanding anything to the contrary provided herein, the
preemptive rights described in this Section 10 shall not apply to (i) the issuance of
Equity Securities for the

18

 

	 	 	exercise of option of follow-on investments by Tiger, (ii) the issuance of Equity Securities
in a Qualified Public Offering, (iii) the issuance by the Company of Common Shares (or
options therefor) to employees, officers, directors or consultants of the Company pursuant to
a stock option plan or other share option plans or other stock incentive arrangements
approved by the Board of the Company, (iv) the issuance of Equity Securities in connection
with a bona fide business acquisition of or by the Company, whether by merger, consolidation,
sale of assets, sale or exchange of stock or otherwise, as a result of which the shareholders
of the Company immediately after such merger, sale or consolidation will not hold securities
representing a majority of the voting power of the outstanding securities of the surviving or
resulting entity, provided that such issuance has obtained required approvals and consents
pursuant to Section 5 hereof, (v) Common Shares issued in connection with any share
split or stock dividend, reclassification or the like; or (vi) the issuance of Equity
Securities pursuant to the conversion, exchange or exercise of any warrant, option, right, or
convertible or exchangeable instrument.
	 
	10.5	 	Assignment. The rights of any Holder under this Section 10 shall only be
assigned (i) to another Holder, (ii) to an Affiliate of such Holder which acquires any of the
Equity Securities thereof (provided that such Affiliate agrees in writing to be bound by the
provisions hereof), or (iii) to an assignee or transferee who acquires all of the Equity
Securities held by the Holder (provided that such assignee or transferee agrees in writing to
be bound by the provisions hereof), (collectively referred to as the “Permitted Assignees”,
and individually referred to as a “Permitted Assignee”.). A Permitted Assignee which is a
Holder shall be entitled to apportion the right of first offer hereby granted it among itself
and its members, partners and Affiliates in such proportions as it deems appropriate.
	 
	10.6	 	Granted Rights. Each of the Holders shall be granted any preemptive rights and
registration rights granted to any subsequent purchasers of the New Securities of the Company
to the extent that such subsequent rights are superior to those granted rights hereof.
	 
	10.7	 	Termination. The rights of the Holders and the obligations of the Company, under
this Section 10 shall terminate immediately prior to the closing of a Qualified Public
Offering.

			
	11.	 	RIGHT OF FIRST REFUSAL, CO-SALE

	11.1	 	Right of First Refusal

	 	(a)	 	Transfer Notice from Shareholders.
	 
	 	 	 	If at any time a Common Shareholder or a Series A Preferred Shareholder (a
“Transferor”) proposes to transfer Equity Securities to one or more third parties
pursuant to an understanding with such third parties (the “Transfer”), then, the
Transferor shall give each of the other non-selling Shareholders (the “Non-Selling
Shareholders”) and the Company written notice of the Transferor’s intention to make
the Transfer (the “Transfer Notice”), provided, however, that the Transferor shall
only give such Transfer Notice to each of the Common Shareholders if the Transferor
is a Series A Preferred Shareholder, which shall include (i) a description of the
Equity Securities to be transferred (“Shares Offered by Shareholder”), (ii) the
identity of the prospective transferee; and (iii) the consideration and the material
terms and conditions upon which the proposed Transfer is to be made. The Transfer
Notice shall be evidence that the Transferor has received a firm offer from the
prospective transferee and in good faith believes a binding agreement for the
Transfer is obtainable on the terms set forth in the Transfer Notice. The Transfer
Notice shall also include a copy of any written proposal,

19

 

	 	 	 	term sheet or letter of intent or other agreement relating to the proposed Transfer.

	 	(b)	 	Non-Selling Shareholders’ Rights of First Refusal.

	 	(i)	 	The Non-Selling Shareholders shall have an option for a period
of thirty (30) days from its receipt of the Transfer Notice to elect to
purchase its respective pro rata shares of the Shares Offered by Shareholder at
the same price and subject to the same material terms and conditions as
described in the Transfer Notice, provided, however that the Sellers shall have
such option provided herein for a period of fifteen (15) days.
	 
	 	(ii)	 	The Non-Selling Shareholders may exercise such purchase option
and, thereby, purchase all or any portion of its pro rata share of the Shares
Offered by Shareholder , by notifying Transferor in writing, before expiration
of the applicable period as provided above as to the number of shares which it
wishes to purchase.
	 
	 	(iii)	 	The Non-Selling Shareholder’s pro rata share of the Shares
Offered by Shareholder shall be a fraction, of which the numerator shall be the
number of Equity Securities owned by such Non-Selling Shareholder on the date
of the Transfer Notice, and the denominator shall be the total number of Equity
Securities held by all the Non-Selling Shareholders on the date of the Transfer
Notice.
	 
	 	(iv)	 	Each of the Non-Selling Shareholders shall be entitled to
apportion its pro rata share of the Shares Offered by Shareholder among its
partners and Affiliates, provided that such Non-Selling Shareholder notifies
the Transferor of such allocation.
	 
	 	(v)	 	If any of the Non-Selling Shareholder gives the Transferor
notice that it desires to purchase its pro rata share of the Shares Offered by
Shareholder (the “Participating Shareholder”), then payment for the Shares
Offered by Shareholder shall be by check or wire transfer, against delivery of
the Shares Offered by Shareholder to be purchased at a place agreed by the
parties and at the time of the scheduled closing therefor, which shall be no
later than the latest of (i) thirty (30) business days after the Non-Selling
Shareholder’s receipt of the Transfer Notice, (ii) the closing date
contemplated in the Transfer Notice and (iii) the date on which the value of
the purchase price is established pursuant to Section 11.1(d).
	 
	 	(vi)	 	In the event any Non-Selling Shareholder elects not to purchase
its full pro rata share of the Shares Offered by Shareholder available
pursuant to its option under Section 11.1(c) within the time period set
forth therein, then the Transferor shall promptly, but in any event within five
(5) days, give written notice (the “Over-allotment Notice”) to each
Participating Shareholder that has elected to purchase all of its pro rata
share of the Shares Offered by Shareholder (each a “Fully Participating
Shareholder”), which notice shall set forth the number of the Shares Offered by
Shareholder not purchased by the other Non-Selling Shareholders (the
“Over-allotment Shares”), and shall offer the Fully Participating Shareholders
the right to acquire the Over-allotment Shares. Each Fully Participating
Shareholder shall have five (5) days after receipt of the Over-allotment Notice
to deliver a written notice to the Transferor of its election to purchase its
pro rata share of the Over-allotment Shares on the same terms and conditions as
set forth in the Transfer Notice and indicating the maximum number

20

 

	 	 	 	of the Over-allotment Shares that it will purchase in the event that any other
Fully Participating Shareholder elects not to purchase its pro rata share of
the Over-allotment Shares. For purposes of this Section 11.1(b), each
Fully Participating Shareholder’s pro rata share of the Over-allotment Shares
shall be a fraction, of which the numerator shall be the number of Equity
Securities owned by such Fully Participating Shareholder on the date of the
Transfer Notice, and the denominator shall be the total number of Equity
Securities held by all the Fully Participating Shareholder on the date of the
Transfer Notice.
	 
	 	(vii)	 	If the Non-Selling Shareholders fail to purchase any or all of
the Shares Offered by Shareholder by exercising the option granted in this
Section 11.1(b) within the period provided, the remaining Shares
Offered by Shareholder shall be subject to the options granted to the Company
pursuant to Section 11.1(c).

	 	 	 	This Section 11.1(b) shall be subject to Section 6.6 of the Purchase Agreement.
	 
	 	(c)	 	The Company’s Right of Refusal.
	 
	 	 	 	Subject to the Non-Selling Shareholders’ option as set forth in Section 11.1(b),
if at any time the Transferor propose a Transfer, within five (5) days after the
Non-Selling Shareholders have declined to purchase all, or a portion, of the Shares
Offered by Shareholder or the Non-Selling Shareholders’ option to so purchase the
Shares Offered by Shareholder has expired, the Transferor shall give the Company an
additional transfer notice (“Additional Transfer Notice”) that shall include all of
the information and certifications required in a Transfer Notice and shall
additionally identify the Shares Offered by Shareholder that the Non-Selling
Shareholders have declined to purchase (the “Remaining Shares”) and briefly describe
the Company’s rights of refusal with respect to the proposed Transfer. The Company
shall have an option for a period of ten (10) days from its receipt of the
Additional Transfer Notice to elect to purchase the Remaining Shares at the same
price and subject to the same material terms and conditions as described in the
Additional Transfer Notice, subject to compliance with the Companies Law of the
Cayman Islands. The Company may exercise such purchase option and purchase all or
any portion of the Remaining Shares by notifying the Transferor in writing before
expiration of such ten (10) day period as to the number of such shares that it
wishes to purchase. If the Company gives the Transferor notice that it desires to
purchase such shares, then payment for the Remaining Shares to be purchased shall be
made by check or wire transfer, against delivery of the Remaining Shares to be
purchased at a place agreed upon between the Company and the Transferor and at the
time of the scheduled closing therefor, which shall be no later than the latest of
(i) thirty (30) business days after the Company’s receipt of the Additional Transfer
Notice, (ii) the closing date contemplated in the Additional Transfer Notice, and
(iii) the date on which the value of the purchase price is established pursuant to
Section 11.1(d).
	 
	 	(d)	 	Valuation of Property.

	 	(i)	 	Should the purchase price specified in the Transfer Notice be
payable in property other than cash or evidences of indebtedness, the Company
or the Non-Selling Shareholders, as the case may be, shall have the right to
pay the purchase price in the form of cash equal in amount to the value of such
property.
	 
	 	(ii)	 	If the Transferor and the Company (or the relevant Non-Selling
Shareholder, as the

21

 

	 	 	 	case may be) fail to agree on such cash value within ten (10) days after the
Company’s (or such Non-Selling Shareholder’s) receipt of the Transfer Notice,
the valuation shall be made by an appraiser of recognized standing selected by
the Transferor and the Company (or the Non-Selling Shareholder, as the case
may be) or, if they fail to agree on an appraiser within twenty (20) days
after the receipt of the Transfer Notice, each shall select an appraiser of
recognized standing and the two appraisers shall designate a third appraiser
of recognized standing, whose appraisal shall be determinative of such value.
	 
	 	(iii)	 	The cost of such appraisal shall be shared equally by the
Transferor and the Company (or the relevant Non-Selling Shareholder(s), as the
case may be, in which case, with the half of the cost to be borne pro rata by
each of such Non-Selling Shareholders based on the number of shares to be
purchased pursuant to this Section 11.1.
	 
	 	(iv)	 	If the closing time for the Company’s (or the Non-Selling
Shareholder’s) purchase as provided in Section 11.1(b)(v) above has
expired but for the determination of the value of the purchase price offered by
the prospective transferee, such closing shall be held on or prior to the fifth
business day after such valuation shall have been made pursuant to Section
11.1(c).

	11.2	 	Right of Co-Sale.

	 	(a)	 	To the extent the Company and the Non-Selling Shareholders do not exercise their
respective rights of first refusal as to all of the Shares Offered by a Shareholder
pursuant to Section 11.1, the Series A Preferred Shareholder and Tiger (each a
“Co-Sale Participant”) which notifies the Transferor in writing within fifty (50) days
after receipt of the Transfer Notice referred to in Section 11.1(a), shall have
the right to participate in such sale of Equity Securities on the same terms and
conditions as specified in the Transfer Notice. Notwithstanding anything to the
contrary provided herein, Tiger shall be entitled to the right of co-sale as endowed by
this Section 11.2 to the extent that the Transferor is any of the Founders
and/or Sellers.
	 
	 	(b)	 	Number of Equity Securities for Co-sale.
	 
	 	 	 	Each Co-Sale Participant may elect to sell up to such number of Equity Securities
equal to (on a fully converted basis) the product of (i) the aggregate number of
Shares Offered by Shareholder covered by the Transfer Notice that have not been
subscribed for pursuant to Section 11.1 above; by (ii) a fraction, the
numerator of which is the number of Equity Securities owned by such Co-Sale
Participant on the date of the Transfer Notice and the denominator of which is the
total number of Equity Securities owned by the Transferor and the Co-Sale Participants
on the date of the Transfer Notice.
	 
	 	(c)	 	The Co-Sale Participant shall effect its participation in the sale by promptly
delivering to the Transferor for transfer to the prospective transferee one or more
certificates, properly endorsed for transfer, which represent the type and number of
Equity Securities which the Co-Sale Participant elects to sell; provided, however that
if the prospective third-party transferee objects to the delivery of Equity Securities
in lieu of Common Shares, the Co-Sale Participant shall convert such Equity Securities
into Common Shares and deliver certificates corresponding to such Common Shares. The
Company agrees to make any such conversion concurrent with the actual
transfer of such shares to the purchaser and

22

 

	 	 	 	contingent on such transfer.
	 
	 	(d)	 	The share certificate or certificates that a Co-Sale Participant delivers to the
Transferor pursuant to Section 11.2(c) shall be transferred to the prospective
transferee in consummation of the sale of the Equity Securities pursuant to the terms
and conditions specified in the Transfer Notice, and the Transferor shall concurrently
therewith remit to such Co-Sale Participant that portion of the sale proceeds to which
such Co-Sale Participant is entitled by reason of its participation in such sale.
	 
	 	(e)	 	To the extent that any prospective transferee prohibits the participation of a
Co-Sale Participant exercising its co-sale rights hereunder in a proposed Transfer or
otherwise refuses to purchase shares or other securities from a Co-Sale Participant
exercising its co-sale rights hereunder, the Transferor shall not sell to such
prospective transferee any Equity Securities unless and until, simultaneously with such
sale, the Transferor shall purchase such shares or other securities from such Co-Sale
Participant for the same consideration and on the same terms and conditions as described
in the Transfer Notice.

	11.3	 	Non-exercise of Rights.
	 
	 	 	To the extent that the Company and the Non-Selling Shareholders have not exercised their
rights to purchase the Shares Offered by Shareholder, the Remaining Shares or the
Over-allotment Shares within the time periods specified in Section 11.1 and the
Series A Preferred Shareholder and Tiger have not exercised their rights to participate in
the sale of the Equity Securities pursuant to and within the time periods specified in
Section 11.2, the Transferor shall have a period of thirty (30) days from the
expiration of such rights to sell the Shares Offered by Shareholder, the Remaining Shares or
the Over-allotment Shares, as the case may be, upon terms and conditions (including the
purchase price) no more favorable than those specified in the Transfer Notice to the
third-party prospective transferee(s) identified in the Transfer Notice. In the event such
Transferor does not consummate the sale or disposition of the Shares Offered by Shareholder,
the Remaining Shares and the Over-allotment Shares within the applicable time period from
the expiration of these rights, the Company’s first refusal rights and the Non-Selling
Shareholders’ first refusal rights and co-sale rights shall continue to be applicable to any
subsequent disposition of the Shares Offered by Shareholder or the Remaining Shares by the
Transferor until such right lapses in accordance with the terms of this Agreement.
Furthermore, the exercise or non exercise of the rights of the Non-Selling Shareholders
under this Section 11 shall not adversely affect their rights to make subsequent
purchases or sales hereunder.
	 
	11.4	 	Limitation to and the Termination of the Rights of First Refusal and Co-sale

	 	(a)	 	Notwithstanding the provisions of this Section 11, a Transferor may sell
or otherwise assign, with or without consideration, Shares to any spouse or member of
such Transferor’s immediate family, or to a custodian, trustee, executor, or other
fiduciary for the account of the Transferor’s spouse or members of the Transferor’s
immediate family, or to a trust for the Transferors’ own self, or a charitable remainder
trust, provided that each such transferee or assignee, prior to the completion of the
sale, transfer, or assignment, shall have agreed in writing to be bound by provisions in
this Agreement.
	 
	 	(b)	 	The rights of first refusal and co-sale rights provided under this Section
11 shall be terminated immediately prior to the closing of a Qualified Public
Offering.

23

 

			
	12.	 	REGISTRATION RIGHTS

	12.1	 	Demand Registration.

	 	(1)	 	Registration Other Than on Form F-3. Subject to the terms of this Section
12, at any time after the earlier of (i) the date that is six (6) months following
the effective date of the registration statement for the IPO, or (ii) the date that is
three (3) years after the Closing, the holders of at least 30% of the aggregate shares
initially purchased by the Series A Preferred Shareholders and Tiger, together on an
as-converted basis, (for the purposes of this Section 12.1, collectively, the
“Initiating Holders”) may request the Company in writing to file a Registration covering
the registration of Registrable Securities for a public offering with anticipated gross
proceeds of at least US$5,000,000 in the aggregate. Upon receipt of such a request, the
Company shall (a) promptly give written notice of the proposed Registration to all other
Holders, and (b) as soon as practicable, and in any event within sixty (60) days of the
receipt of such request, cause Registrable Securities specified in the request, to be
Registered and/or qualified for sale and distribution in such jurisdictions as the
Initiating Holders may reasonably request.
	 
	 	 	 	Notwithstanding the foregoing and subject to Section 12.1(3) below, the
Company shall not be required to effect a registration pursuant to this Section
12.1(1):

	 	(a)	 	with respect to a Registration initiated pursuant to Section
12.1(1), after the Company has effected two (2) Registrations pursuant to
this Section 12.1(1), and such Registration have been declared or ordered
effective (and have not been subject to a stop order or otherwise withdrawn); or
	 
	 	(b)	 	if the Initiating Holders propose to dispose of Registrable
Securities that may be registered on Form F-3 pursuant to Section 12.1(2)
hereof;

	 	(2)	 	Registration on Form F-3. Subject to the terms of this Agreement, at any time
after a Qualified Public Offering, the Initiating Holders may request the Company in
writing to file a Registration on Form F-3 (or any successor form to Form F-3, or any
comparable form for Registration in a jurisdiction other than the United States, to the
extent that the Company is qualified to use such form to register the requested
Registrable Securities) for a public offering of all or a part of the Registrable
Securities owned by such Initiating Holders. Upon receipt of such a request, the Company
shall, (a) promptly give written notice of the proposed registration to all other
Holders, and (b) as soon as practicable, and in any event within sixty (60) days of the
receipt of such request, cause the Registrable Securities specified in the request, to
be registered and qualified for sale and distribution in such jurisdictions as the
Initiating Holders may reasonably request. The Initiating Holders may at any time, and
from time to time, require the Company to effect the Registration of Registrable
Securities under this Section 12.1(2), provided that the Company shall
not be obligated to effect more than two (2) Registrations on demand of the Initiating
Holders any 12-month period pursuant to this Section 12.1(2).
	 
	 	 	 	Notwithstanding the foregoing and subject to Section 12.1(3) below, the Company shall
not be required to effect a registration pursuant to this Section 12.1(2):

	 	(a)	 	if Form F-3 (or its comparable form) is not available for such
offering by the Holders; or

24

 

	 	(b)	 	if the Holders, together with the holders of any other securities
of the Company entitled to inclusion in such registration, propose to sell
Registrable Securities and such other securities (if any) at an aggregate price
to the public (net of any underwriters’ discounts or commissions) of less than
US$500,000.

	 	(3)	 	Right of Deferral.

	 	(a)	 	the Company shall be entitled to postpone or suspend, for a
reasonable period of time, the filing, effectiveness or use of, or trading under,
any registration statement as requested by the Initiating Holders pursuant to
Section 12.1(1) or 12.1(2), if the Company shall determine that
any such filing or the sale of any securities pursuant to such registration
statement would in the good faith judgment of the Board:

	 	(i)	 	materially impede, delay or interfere with any material
pending or proposed financing, acquisition, corporate reorganization or
other similar transaction involving the Company for which the Board has
authorized negotiations; or
	 
	 	(ii)	 	require disclosure of material nonpublic information
that, if disclosed at such time, would be materially harmful to the
interests of the Company and its shareholders; provided,
however that during any such period all executive officers and
directors of the Company are also prohibited from selling securities of the
Company (or any security of any of the Company’s Subsidiaries or
Affiliates);

	 	(b)	 	if, after receiving a request from the Initiating Holders pursuant
to Section 12.1(1) or Section 12.1(2), the Company furnishes to
each Initiating Holder a certificate signed by the Chief Executive Officer of the
Company stating that, in the good faith judgment of the Board of the Company, it
would be seriously detrimental to the Company or its shareholders for a
registration statement to be filed in the near future, the Company’s obligation
to use its commercially reasonable efforts to file a registration statement shall
be deferred for a period not to exceed ninety (90) days from the receipt of any
request duly submitted by the Initiating Holders under Section 12.1(1) or
12.1(2) to register Registrable Securities; provided that the
Company shall not exercise the right contained in this Section 12.1(3)(b)
more than once in any twelve (12) month period; and provided
further that the Company shall not register any securities of the Company
for the account of itself or any other shareholder during such ninety (90) day
period.

	 	(4)	 	Underwritten Offerings. If, in connection with a request to register Registrable
Securities under Section 12.1(1) or Section 12.1(2), the Initiating
Holders intend to distribute such Registrable Securities by means of an underwriting,
they shall so advise the Company as a part of the request, and the Company shall include
such information in the written notice to the other Holders. In such event, the right
of any Holder to include its Registrable Securities in such Registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of
such Holder’s Registrable Securities in the underwriting to the extent provided herein.
All Holders proposing to distribute their securities through such underwriting shall
enter into an underwriting agreement in customary form with the underwriter or
underwriters selected for such underwriting by a majority in interest of the Initiating
Holders (which underwriter or underwriters shall be reasonably acceptable to the
Company). Notwithstanding any other provision of this Agreement, if the underwriter
advises the Company that marketing factors (including the

25

 

	 	 	 	aggregate number of securities requested to be registered, the general condition of
the market, and the status of the Persons proposing to sell securities pursuant to the
Registration) require a limitation of the number of securities underwritten (including
Registrable Securities), then the Company shall so advise all Holders that would
otherwise be underwritten pursuant hereto, and the number of shares that may be
included in the underwriting shall be allocated to such Holders pro rata based on the
number of Registrable Securities held by all such Holders (including the Initiating
Holders). In no event shall any Registrable Securities be excluded from such
underwriting unless all other securities are first excluded. Any Registrable
Securities excluded or withdrawn from such underwriting shall be withdrawn from the
Registration.

	12.2	 	Piggyback Registrations

	 	(1)	 	Registration of the Company’s Securities. Subject to Section 12.2(3), if
the Company proposes to register for its own account (including for this purpose a
registration statement filed by the Company for shareholders other than the Holders) any
of its Equity Securities in connection with the public offering of such securities, the
Company shall promptly give each Holder written notice of such Registration and, upon
the written request of any Holder given within twenty (20) days after delivery of such
notice, the Company shall use commercially reasonable efforts to include in such
Registration any Registrable Securities thereby requested by the Holders. The Holders’
right to demand the piggyback registration pursuant to this Section 12.2 is
unlimited.
	 
	 	(2)	 	Right to Terminate Registration. The Company shall have the right to terminate
or withdraw any Registration initiated by it under Section 12.2(1) prior to the
effectiveness of such Registration, whether or not any Holder has elected to include
Registrable Securities in such Registration. The expenses of such withdrawn Registration
shall be borne by the Company in accordance with Section 12.3.
	 
	 	(3)	 	Underwriting Requirements.

	 	(a)	 	In connection with any offering involving an underwriting of the
Company’s Equity Securities, the Company shall not be required under this
Section 12.2 to include any Holder’s Registrable Securities in such
underwriting unless such Holder enters into an underwriting agreement in
customary form with the underwriters selected by the Company and setting forth
such terms for the underwriting as have been agreed upon between the Company and
the underwriters. In the event the underwriters advise the Holders seeking
Registration of Registrable Securities pursuant to this Section 12.2 in
writing that market factors (including the aggregate number of Registrable
Securities requested to be Registered, the general condition of the market, and
the status of the persons proposing to sell securities pursuant to the
Registration) require a limitation of the number of Equity Securities to be
underwritten, then the Company shall be required to include in the offering only
that number of such securities, including Registrable Securities, that the
underwriters may advise will not jeopardize the success of the offering. In no
event shall any Registrable Securities be excluded from such offering unless all
other selling shareholders’ securities have been first excluded. In the event
that the underwriters advise that less than all of the Registrable Securities
requested to be registered can be included in such offering, then the Registrable
Securities that are included in such offering shall be apportioned pro rata among
the selling Holders based on the number of Registrable Securities held by all
selling Holders or in such other proportions as shall mutually be agreed to

26

 

	 	 	 	by all such selling Holders. Notwithstanding the foregoing, in no event shall
the amount of securities included in the Registration on behalf of the Holders
be reduced below thirty percent (30%) of the total shares requested to be
included by the Holders in such offering, unless such offering is the Qualified
Public Offering, in which case the amount of securities of Tiger included in the
offering may be reduced on the basis and as advised by the underwriters as
provided above, including completely, if, no other shareholder’s securities are
included in such offering. For purposes of the preceding sentence concerning
apportionment, for any selling shareholder that is a Holder of Registrable
Securities and that is an investment fund, partnership, limited liability
company or corporation, the affiliated investment funds, partners, members,
retired partners, retired members and shareholders of such Holder, or the
estates and family members of any such partners, members, retired members and
retired partners and any trusts for the benefit of any of the foregoing persons
shall be deemed to be a single selling Holder, and any pro rata reduction with
respect to such selling Holder, shall be based upon the aggregate amount of
Registrable Securities owned by all such related entities and individuals.
	 
	 	(b)	 	If any Series A Preferred Shareholder disapproves of the terms of
any underwriting, such Preferred Shareholder may elect to withdraw therefrom by
written notice to the Company and the underwriters delivered at least seven (7)
days prior to the effective date of the registration statement. Any Registrable
Securities excluded or withdrawn from the underwriting shall be withdrawn from
the Registration.

	12.3	 	Procedures.

	 	(1)	 	Registration Procedures and Obligations. Subject to provisions under Section
12.1(3), whenever required under this Agreement to effect the Registration of any
Registrable Securities held by a Holder, the Company shall, as expeditiously as
possible:

	 	(a)	 	Prepare and file with the Commission a registration statement with
respect to those Registrable Securities and use its reasonable best efforts to
cause that registration statement to become effective, and, upon the request of
the Holders of thirty percent (30%) of the Registrable Securities registered
thereunder, keep such registration statement effective for a period of up to one
hundred twenty (120) days or, if earlier, until the distribution contemplated in
the Registration Statement has been completed;
	 
	 	(b)	 	Prepare and file with the Commission amendments and supplements to
that registration statement and the prospectus used in connection with the
registration statement as may be necessary to comply with the provisions of
Applicable Securities Law with respect to the disposition of all securities
covered by the registration statement;
	 
	 	(c)	 	Furnish to the Holders the number of copies of a prospectus,
including a preliminary prospectus, required by Applicable Securities Law, and
any other documents as they may reasonably request in order to facilitate the
disposition of Registrable Securities owned by them;
	 
	 	(d)	 	Use its reasonable best efforts to register and qualify the
securities covered by the registration statement under the securities laws of any
jurisdiction, as reasonably requested by the Holders, provided that the
Company shall not be required to qualify to do business or file a general consent
to service of process in any such jurisdictions;

27

 

	 	(e)	 	In the event of any underwritten public offering, enter into and
perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter of the offering;
	 
	 	(f)	 	Notify each Holder of Registrable Securities covered by the
registration statement at any time when a prospectus relating thereto is required
to be delivered under Applicable Securities Law or of the happening of any event
as a result of which any prospectus included in the registration statement, as
then in effect, includes an untrue statement of a material fact or omits to state
a material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing;
	 
	 	(g)	 	Provide a transfer agent and registrar for all Registrable
Securities registered pursuant to the registration statement and, where
applicable, a CUSIP number for all those Registrable Securities, in each case not
later than the effective date of the Registration;
	 
	 	(h)	 	Furnish, at the request of any Preferred Shareholder requesting
Registration of Registrable Securities pursuant to this Agreement, on the date
that such Registrable Securities are delivered for sale in connection with a
Registration pursuant to this Agreement, (i) an opinion, dated the date of the
sale, of the counsel representing the Company for the purposes of the
Registration, in form and substance as is customarily given to underwriters in an
underwritten public offering; and (ii) a comfort letter dated the date of the
sale, from the independent certified public accountants of the Company, in form
and substance as is customarily given by independent certified public accountants
to underwriters in an underwritten public offering, addressed to the
underwriters; and
	 
	 	(i)	 	Take all reasonable action necessary to cause all such Registrable
Securities registered pursuant to this Section 12.3(1) to be listed or
admitted for quotation on the primary exchange upon which the Company’s
securities are then listed or admitted for quotation.

	 	(2)	 	Information from Holders. It shall be a condition precedent to the obligations
of the Company to take any action pursuant to this Agreement with respect to the
Registrable Securities of any selling Holder that the such Holder shall furnish to the
Company such information regarding itself, the Registrable Securities held by it, and
the intended method of disposition of such securities as shall be required to effect the
Registration of such Holder’s Registrable Securities.
	 
	 	(3)	 	Expenses of Registration. All expenses, other than Selling Expenses, incurred in
connection with Registrations, filings or qualifications pursuant to this Agreement,
including (without limitation) all Registration, filing and qualification fees,
printers’ and accounting fees, fees and disbursements of counsel for the Company and
disbursements of one counsel of the selling Holders, shall be borne by the Company.
	 
	 	(4)	 	Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any Registration as the result of any
controversy that may arise with respect to the interpretation or implementation of this
Section 12.
	 
	 	(5)	 	IPO Preparation. In anticipation of the IPO, the Company shall have the right to
designate the Company’s Chief Financial Officer and its principle and accounting and
legal firms,

28

 

	 	 	 	provided that such person and firms are acceptable to the Holders.

	12.4	 	Indemnification under Registration Rights.

	 	(1)	 	Company Indemnity.

	 	(a)	 	To the extent permitted by law, the Company will indemnify and hold
harmless each Holder, the partners, officers, directors, shareholders of each
Holder, legal counsel and accountants for each Holder, any underwriter (as
defined in the Securities Act) for such Holders and each Person, if any, who
controls (as defined in the Securities Act) such Holder against any losses,
claims, damages or liabilities (joint or several) to which they may become
subject to under laws which are applicable to the Company and relate to action or
inaction required of the Company in connection with any Registration,
qualification, or compliance, insofar as such losses, claims, damages, or
liabilities (or actions in respect thereof) arise out of or are based upon any of
the following statements, omissions or violations (each a “Violation”): (i) any
untrue statement or alleged untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission or
alleged omission to state in the registration statement, including any
preliminary prospectus or final prospectus contained therein or any amendments or
supplements thereto, a material fact required to be stated therein or necessary
to make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of Applicable Securities Laws, or any rule or regulation
promulgated under Applicable Securities Laws. The Company will reimburse each
such Holder, underwriter or controlling person or other aforementioned persons
for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action.
	 
	 	(b)	 	The indemnity agreement contained in this Section 11.4(1)
shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of the
Company (which consent shall not be unreasonably withheld), nor shall the Company
be liable in any such case for any such loss, claim, damage, liability or action
to the extent that it arises out of or is based upon a Violation that occurs in
reliance upon and in conformity with written information furnished expressly for
use in connection with such Registration by any such Holder, underwriter or
controlling person.
	 
	 	(c)	 	With respect to any preliminary prospectus, the foregoing indemnity
shall not inure to the benefit of any Holder or underwriter, or any Person
controlling (within the meaning of the Securities Act) such Holder or
underwriter, from whom the Person asserting any such losses, claims, damages or
liabilities purchased shares in the offering, if a copy of the prospectus (as
then amended or supplemented if the Company shall have furnished any amendments
or supplements thereto) was not sent or given by or on behalf of such Holder or
underwriter to such Person, if required by law to have been so delivered, at or
prior to the written confirmation of the sale of the shares to such Person, and
if the prospectus (as so amended or supplemented) would have cured the defect
giving rise to such loss, claim, damage or liability.

	 	(2)	 	Holder Indemnity.

29

 

	 	(a)	 	To the extent permitted by law, each selling Holder will indemnify
and hold harmless the Company, its directors, officers who has signed the
registration statement, legal counsel and accountants, any underwriter, and each
Person, if any, who controls (within the meaning of the Securities Act) the
Company or such underwriter, against any losses, claims, damages or liabilities
(joint or several) to which any of the foregoing persons may become subject,
under Applicable Securities Laws, or any rule or regulation promulgated under
Applicable Securities Laws, insofar as such losses, claims, damages or
liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such
Violation occurs in reliance upon and in conformity with written information
furnished by the selling Holders expressly for use in connection with such
Registration; and such selling Holder will reimburse any person intended to be
indemnified pursuant to this Section 12.4(2), for any legal or other
expenses reasonably incurred by such person in connection with investigating or
defending any such loss, claim, damage, liability or action.
	 
	 	(b)	 	The indemnity contained in this Section 12.4(2) shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability or
action if such settlement is effected without the consent of such selling Holders
(which consent shall not be unreasonably withheld), and in no event shall any
indemnity under this Section 12.4(2) exceed the gross proceeds from the
offering received by such selling Holder.

	 	(3)	 	Notice of Indemnification Claim. Promptly after receipt by an indemnified party
under Section 12.4(1) or Section 12.4(2) of notice of the commencement
of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under Section
12.4(1) or Section 12.4(2), deliver to the indemnifying party a written
notice of the commencement thereof and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly with any
other indemnifying party similarly noticed, to assume the defense thereof with counsel
mutually satisfactory to the indemnifying parties. An indemnified party (together with
all other indemnified parties that may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses to be
paid by the indemnifying party, if representation of such indemnified party by the
counsel retained by the indemnifying party would be inappropriate due to actual or
potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to
the indemnifying party within a reasonable time of the commencement of any such action,
if prejudicial to its ability to defend such action, shall relieve such indemnifying
party of any liability to the indemnified party under this Section 12.4, but the
omission to deliver written notice to the indemnifying party will not relieve it of any
liability that it may have to any indemnified party otherwise than under this
Section 12.4.
	 
	 	(4)	 	Contribution. If any indemnification provided for in Section 12.4(1) or
Section 12.4(2) is held by a court of competent jurisdiction to be unavailable
to an indemnified party with respect to any loss, liability, claim, damage or expense
referred to herein, the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage or expense in such proportion
as is appropriate to reflect the relative fault of the indemnifying party, on the one
hand, and of the indemnified party, on the other, in connection with the statements or
omissions that resulted in such loss, liability, claim,

30

 

	 	 	 	damage or expense, as well as any other relevant equitable considerations. The
relative fault of the indemnifying party and of the indemnified party shall be
determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the
parties’ relative intent, knowledge, access to information, and opportunity to correct
or prevent such statement or omission.
	 
	 	(5)	 	Underwriting Agreement. To the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the
provisions in the underwriting agreement shall control.
	 
	 	(6)	 	Survival. The obligations of the Company and the selling Holders under this
Section 12.4 shall survive the closing of any offering of Registrable Securities
in a registration statement under this Agreement, and otherwise.

	12.5	 	Additional Undertakings.

	 	(1)	 	Reports under the Exchange Act. With a view to making available to the Holders
the benefits of Rule 144 promulgated under the Securities Act and any comparable
provision of any Applicable Securities Law that may at any time permit a Holder to sell
securities of the Company to the public without Registration or pursuant to a
Registration on Form F-3 (or any comparable form in a jurisdiction other than the United
States), the Company agrees to:

	 	(a)	 	make and keep public information available, as those terms are
understood and defined in Rule 144 (or comparable provision under Applicable
Securities Laws in any jurisdiction where the Company’s securities are listed),
at all times after the effective date of a Qualified Public Offering;
	 
	 	(b)	 	file with the Commission in a timely manner all reports and other
documents required of the Company under all Applicable Securities Laws; and
	 
	 	(c)	 	at any time following ninety (90) days after the effective date of
the Qualified Public Offering, promptly furnish to any Holder, upon request (i) a
written statement by the Company that it has complied with the reporting
requirements of all Applicable Securities Laws at any time after it has become
subject to such reporting requirements or, at any time after so qualified, that
it qualifies as a registrant whose securities may be resold pursuant to Form F-3
(or any form comparable thereto under Applicable Securities Laws of any
jurisdiction where the Company’s securities are listed), (ii) a copy of the most
recent annual or quarterly report of the Company and such other reports and
documents as may be filed by the Company with the Commission, and (iii) such
other information as may be reasonably requested in availing such Holder of any
rule or regulation of the Commission, that permits the selling of any such
securities without Registration or pursuant to such form.

	 	(2)	 	Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of a
majority of the Registrable Securities, enter into any agreement with any holder or
prospective holder of any Equity Securities of the Company that would allow such holder
or prospective holder (a) to include such securities in any Registration filed under
Section 12.2, unless under the terms of such agreement such holder or
prospective holder may include such Equity

31

 

	 	 	 	Securities in any such Registration only to the extent that the inclusion of such
securities will not reduce the amount of the Registrable Securities of the Holders
that are included, (b) to demand Registration of their securities, or (c) to enjoy
registration rights otherwise superior to or in parity with those of the Holders as
endowed by this Agreement.
	 
	 	(3)	 	“Market Stand-Off” Agreement. The Holders agree that it will not, without the
prior written consent of the managing underwriter, during the period commencing on the
date of the final prospectus relating to the Company’s IPO and ending on the date
specified by the Company and the managing underwriter (such period not to exceed one
hundred and eighty (l80) days) (i) lend, offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any shares of Equity Securities (whether then owned or thereafter acquired)
or (ii) enter into any swap or other arrangement that transfers to another, in whole or
in part, any of the economic consequences of ownership of the Equity Securities, whether
any such transaction described in Section (i) or (ii) above is to be
settled by delivery of Equity Securities or such other securities, in cash or otherwise.
The foregoing provision of this Section 12.5(3) shall apply only to the
Company’s Qualified Public Offering and shall only be applicable to the Holders if all
officers, directors and greater than 1% shareholder of the Company enter into similar
agreements to the extent requested by the managing underwriter. The underwriters in
connection with the Company’s IPO are intended third party beneficiaries of this
Section 12.5(3) and shall have the right, power and authority to enforce the
provisions hereof as though they were a party hereto. In order to enforce the foregoing
covenant, the Company may impose stop-transfer instructions with respect to the
Registrable Securities of each Holder (and the shares or securities of every other
person subject to the foregoing restriction) until the end of such period.
	 
	 	(4)	 	Each Holder agrees that a legend reading substantially as follows shall be placed
on all certificates representing all Registrable Securities of each
Holder (and the shares or securities of every other person subject to the restriction contained in this
Section 12.5(3)):
	 
	 	 	 	THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP
PERIOD OF UP TO 180 DAYS AFTER THE EFFECTIVE DATE OF THE ISSUER’S INITIAL PUBLIC
OFFERING AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF
THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE.
SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES.
	 
	 	(5)	 	Assignment of Registration Rights. The rights to cause the Company to Register
Registrable Securities pursuant to this Agreement may be assigned (but only with all
related obligations under this Agreement) by a Holder to a transferee or assignee of
such securities that (i) is an Affiliate of such Holder, or (ii) after such assignment
or transfer, holds Registrable Securities representing at least 50% Common Shares
(subject to appropriate adjustment for stock splits, stock dividends, combinations and
other recapitalizations), provided that: (a) the Company is, within a reasonable time
after such transfer, furnished with written notice of the name and address of such
transferee or assignee and the securities with respect to which such registration rights
are being assigned; (b) such transferee or assignee agrees in writing to be bound by and
subject to the terms and conditions of this Agreement; (c) such transfer or assignment
shall be effective only if immediately following such transfer or assignment the further
disposition of such securities by the transferee or assignee is restricted under
Applicable Securities Law; (d) the transferee is not a business

32

 

	 	 	 	competitor of the Company; (e) the transfer is in connection with a transfer of all
securities of the transfer; and (f) the transfer is to constituent partners or
shareholders who agree to act through a single representative. In the event of a
transfer or assignment of Registrable Securities which does not satisfy the conditions
set forth above, such securities shall no longer be deemed to constitute “Registrable
Securities” for purposes of this Agreement.
	 
	 	(6)	 	Exercise of Series A Preferred Shares. Notwithstanding anything to the contrary
provided in this Agreement, the Company shall have no obligation to Register Registrable
Securities which, if constituting Common Share Equivalents, have not been exercised,
converted or exchanged, as applicable, for Common Shares.

	12.6	 	Termination of the Registration Right. No Holder shall be entitled to exercise any
right provided for in this Section 12 after five (5) years following the consummation
of the Qualified Public Offering or (b) as to any Holder, such earlier time after the
Qualified Public Offering at which such Holder (i) can sell all shares held by it in
compliance with Rule 144(b)(1)(i) or (ii) holds one percent (1%) or less of the Company’s
outstanding Common Shares and all Registrable Securities held by such Holder (together with
any Affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) can
be sold in any ninety (90) day period without registration in compliance with Rule 144.

			
	13.	 	REDEMPTION RIGHT

	13.1	 	Redemption Right. Subject to the terms and conditions of this Agreement and to the
extent permitted by applicable laws, at any time and from time to time after December 31,
2011, at the written request for redemption (made on one or more occasions) by the Series A
Preferred Shareholder then outstanding, concurrently with surrender by such holder of
certificates representing its Series A Preferred Shares, the Company shall redeem all the
Series A Preferred Shares as may be requested by such holder.
	 
	13.2	 	Redemption Price. The redemption price per Share at which such redemption shall be
made by the Company for the number of Preferred Shares as requested to be redeemed shall be
one hundred and eighty percent (180%) of the Original Issue Price. The Company shall pay such
amount on each of the Series A Preferred Shares to be redeemed on the redemption date
specified in the request of such Preferred Shareholder.
	 
	13.3	 	Unredeemed Shares. If on the date of redemption, the number of Preferred Shares that
may then be legally redeemed by the Company is less than the number of Preferred Shares to be
redeemed, then any unredeemed preferred shares will be carried forward and redeemed as soon as
the Company is legally able to do so. If the Company does not have sufficient cash legally
available to redeem all of the Preferred Shares required to be redeemed, the remainder of the
unredeemed Preferred Shares will be paid in the form of a one-year note to the Preferred
Shareholder bearing an interest of 25% for Series A Preferred Shares.

			
	14.	 	SHARE PREFERENCES; DOCUMNENT RELATIONS

	14.1	 	Share Preference. Subject to other terms in this Agreement, the rights, preferences
and privileges attached to the Series A Preferred Shares shall not be subordinated to those
attached to any other class of Shares, and will at all times be at least pari passu with the
rights attached to all other Shares, including currently issued and outstanding Common Shares
or Preferred Shares or any other Shares to be issued in the future, unless each of the Series
A Preferred Shareholder gives its prior written consent to the Company’s issuance of any new
class of securities of the Company or

33

 

	 	 	assignment to existing securities having or receiving rights, preferences or privileges in
parity with or senior to the Series A Preferred Shares.

			
	15.	 	NOTICE

	15.1	 	Any notice or other communication given or made under this Agreement shall be in writing.
	 
	15.2	 	Any such notice or other communication shall be addressed as provided in this Section
14 and, if so addressed, shall be deemed to have been duly given or made as follows:

	 	(a)	 	if sent by personal delivery, upon delivery at the address of the relevant
Party;
	 
	 	(b)	 	if sent by registered post, five (5) Business Days after the date of posting;
and
	 
	 	(c)	 	if sent by facsimile, upon despatch to the facsimile number of the recipient,
with the production of a transmission report by the machine from which the facsimile
was sent which indicates that the facsimile was sent in its entirety to the facsimile
number of the recipient.

	15.3	 	The relevant address and facsimile number of each Party for the purposes of this Agreement
are set out in the relevant schedule as attached to the Share Purchase Agreement.
	 
	15.4	 	A Party may notify the other Parties to this Agreement of a change to its/his name, address
or facsimile number for the purpose of this Section PROVIDED THAT such notification shall
only be effective on:

	 	(a)	 	if Sub-Section (ii) does not apply, the date specified in the notification as
the date on which the change is to take place; or
	 
	 	(b)	 	if no date is specified or the date specified is less than seven (7) Business
Days after (and excluding) the date on which the notice is given, the date falling
seven (7) Business Days after notice of any such change has been given.

			
	16.	 	MISCELLANEOUS

	16.1	 	Successors and Assigns.

	 	(a)	 	Series A Preferred Shareholder shall be entitled to transfer all or part of its
Series A Preferred Shares to one or more affiliated partnerships or funds managed by or
affiliated with it or any of their respective directors, officers or partners, provided
such transferee agrees in writing to be subject to the terms of the Share Purchase
Agreement and related agreements as if it were a purchaser of such Series A Preferred
Shares thereunder.
	 
	 	(b)	 	Subject to sub-Section (i) above, this Agreement is personal to the Parties
hereto and save as expressly provided herein, none of them may assign, mortgage, charge
or sub-license any of their respective rights herein, or sub-contract or otherwise
delegate any of its obligations herein, except with the prior written consent of the
other Parties hereto.
	 
	 	(c)	 	Subject to sub-Section (ii) above, this Agreement shall be binding on and inure
for the benefit of the successors, permitted assigns and personal representatives (as
the case may be) of each of the Parties hereto.

34

 

	 	(d)	 	Notwithstanding the above, it is agreed that Series A Preferred Shareholders
may, subject to Section 10.1 hereof, transfer and assign all the rights and
obligations hereunder to any third parties without prior written consent of any other
party in this agreement except to a transferee or assignee who is a direct or indirect
competitor of the Group Entities and except that any such transfer will at the
reasonable discretion of the Company have material adverse impact on the business of
Group Entities, and it is further agreed that any such transfer conducted by Series A
Preferred Shareholders causing adverse material impact on the business of Group Entity
should be null and void on and after the date when such transfer is executed. To avoid
doubt, the Sellers’ not exercising the Right of First Refusal under this Agreement
should not be construed as a waiver of the Indemnitees to their right hereunder in the
event that such transfer conducted by Series A Preferred Shareholder has material
adverse impact on the business of Group Entities. Any transfer in violation of this
sub-Section (iv) shall constitute breach of this Agreement.
	 
	 	(e)	 	Subject to sub-Section (vi) below, without prior written consent from all
Preferred Shareholders, any Common Shareholder shall not assign or transfer its Equity
Securities in the Company to any third party. The aforesaid share transfer restriction
will expire upon the closing of Qualified IPO.
	 
	 	(f)	 	Notwithstanding the sub-Section (v) above but subject to Section 10.1
hereof, each Seller shall be entitled to, without prior consent of the Series A
Preferred Shareholder, transfer up to 8% of the total number of Shares held by such
transferring Seller at the time of Closing to the investors if and when such transfer
is associated with, and conducted concurrently with, a new round of financing for the
Company, and the Series A Preferred Shareholder shall take all necessary action, and
shall procure the Director it nominated or appointed in the Board of Director of the
Company to take all necessary action, including but not limited to vote in favor of
such transfer in the relevant resolutions. To avoid doubt, this sub-Section (vi)
provided herein is not subject to Section 9 of this Agreement.

	16.2	 	Cumulative Rights.
	 
	 	 	Unless otherwise provided in this Agreement, any remedy conferred on any Party hereto for
breach of this Agreement shall be in addition and without prejudice to all other rights and
remedies available to it.
	 
	16.3	 	Entire Agreement; Amendments.
	 
	 	 	This Agreement shall supersede all and any previous agreements, understandings or
arrangements (if any) between and among the Parties hereto or any of them in relation to the
subject matter hereof and all or any such previous agreements, understandings or
arrangements (if any) shall cease and determine with effect from the date hereof. This
Agreement constitutes the whole agreement between and among the Parties hereto or any of
them in relation to the subject matter hereof (no Party having relied on any representation,
warranty or undertaking made by any other party which is not a term of this Agreement).
	 
	 	 	Any term of this Agreement may be amended and the observance of any term of this Agreement
may be waived (either generally or in a particular instance and either retroactively or
prospectively), only with the written consent of each of (i) the Company, (ii) the Series A
Preferred Shareholder representing more than 50% of all Series A Preferred Shares, (iii)
Sellers, and (iv) Tiger. Any amendment or waiver effected in accordance with this paragraph
shall be

35

 

	 	 	binding upon the Parties and their respective successors and assigns.
	 
	16.4	 	Further Assurance.
	 
	 	 	Each of the Parties hereto undertakes with each of the other Parties that it shall do, or
shall procure to be done, all such acts and things and shall execute, or shall procure to be
executed, all such documents as may be necessary or appropriate to implement the provisions
of this Agreement or otherwise to give full legal force and effect thereof.
	 
	16.5	 	Severability.
	 
	 	 	The Parties hereto intended that the provisions of this Agreement shall be enforced to the
maximum extent permissible under the laws applied in each jurisdiction in which enforcement
of any provisions of this Agreement is sought. If any particular provision or part of this
Agreement shall be held to be invalid or unenforceable, this Agreement shall be deemed to be
amended by the deletion of the provision or part held to be invalid or unenforceable or, to
the extent permissible by the applicable laws of the relevant jurisdiction in which such
enforcement is sought, such provision or part shall be deemed to be varied in such a way as
to achieve most closely the purpose of the original provision or part in a manner which is
valid and enforceable, provided that for the avoidance of doubt, such amendments shall apply
only with respect to the operation of this Agreement in the particular jurisdiction in which
the decision as to invalidity or unenforceability is made.
	 
	16.6	 	Non-waiver.
	 
	 	 	No delay or omission on the part of any Party hereto in exercising any right, power or
privilege shall operate to impair such right, power or privilege or be construed as a waiver
by such Party of the same and no single or partial exercise or non-exercise or delay in
exercising any right, power or privilege by any Party hereto shall in any circumstances
preclude any other or further exercise by such Party of such right, power or privilege or
the exercise of any other right, power or privilege by such Party.
	 
	16.7	 	Counterparts.
	 
	 	 	This Agreement may be executed in counterparts and by different Parties hereto on separate
copies or counterparts and which taken together shall constitute one and the same agreement.
The facsimile transmissions of any executed original document (including without limitation,
any page of an original document on which an original signature appears) and/or
retransmission of any such facsimile transmission shall be deemed to be the same as the
delivery of an executed original. At the request of any Party hereto, the other Parties
hereto shall confirm facsimile transmissions by executing duplicate original documents and
delivering the same to the requesting party or parties.
	 
	16.8	 	Dispute Resolution; Governing Law.

	 	(a)	 	This Agreement shall be governed by and construed in accordance with the Law of
the State of New York as to matters within the scope thereof, without regard to its
principles of conflicts of laws.
	 
	 	(b)	 	Any dispute, controversy or claim arising out of or relating to this Agreement,
or the interpretation, breach, termination or validity hereof, shall be resolved
through consultation. Such consultation shall begin immediately after one Party hereto
has delivered to the other

36

 

	 	 	 	Party hereto a written request for such consultation. If within thirty (30) days
following the date on which such notice is given the dispute cannot be resolved, the
dispute shall be submitted to arbitration upon the request of either Party with notice
to the other.
	 
	 	(c)	 	The arbitration shall be conducted in Hong Kong under the auspices of Hong Kong
International Arbitration Commission Center (“HKIAC”) in accordance with its
arbitration rules. If the parties do not agree to appoint the arbitrator(s) who
has/have consented to participate within thirty (30) days after a notice of
arbitration, the relevant appointment shall be made by HKIAC.
	 
	 	(d)	 	The arbitration proceedings shall be conducted in English.
	 
	 	(e)	 	The arbitrators shall decide any dispute submitted by the Parties to the
arbitration strictly in accordance with the substantive law of New York and shall not
apply any other substantive law.
	 
	 	(f)	 	Each Party hereto shall cooperate with the other(s) in making full disclosure
of and providing complete access to all information and documents requested by the
other in connection with such arbitration proceedings, subject only to any
confidentiality obligations binding on such party.
	 
	 	(g)	 	The award of the arbitration tribunal shall be final and binding upon the
disputing parties, and the prevailing party may apply to a court of competent
jurisdiction for enforcement of such award.
	 
	 	(h)	 	Any Party in dispute with another shall be entitled to seek preliminary
injunctive relief from any court of competent jurisdiction pending the constitution of
the arbitral tribunal.

	16.9	 	This Agreement shall take effect, after being duly executed and delivered by all the Parties
hereto, upon the effectiveness of the Share Purchase Agreement.
	 
	16.10	 	Cross-Guarantees.
	 
	 	 	Each of Zhang Bangxin, Cao Yundong, LIU Yachao and BAI Yunfeng shall unconditionally
guarantees the performance of BRIGHT UNISON LIMITED, CENTRAL GLORY INVESTMENTS LIMITED,
PERFECT WISDOM INTERNATIONAL LIMITED and EXCELLENT NEW LIMITED respectively under this
Agreement and vice versa, each of BRIGHT UNISON LIMITED, CENTRAL GLORY INVESTMENTS LIMITED,
PERFECT WISDOM INTERNATIONAL LIMITED and EXCELLENT NEW LIMITED shall unconditionally
guarantees the performance of Zhang Bangxin, Cao Yundong, LIU Yachao and BAI Yunfeng
respectively under this Agreement.
	 
	16.11	 	Power of Attorney.
	 
	 	 	KTB hereby authorizes the Company, on behalf of itself and as agent for KTB, to enter into
the Assumption Agreement in the form attached as Exhibit B-2 of the Purchase Agreement
pursuant to Section 6.23 thereunder.

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

37

 

     IN WITNESS WHEREOF, the parties have executed this Shareholder’ Agreement as of the date first
written above.

	 	 	 	 	 
	SELLERS	BRIGHT UNISON LIMITED

 	 
	 	By:  	/s/
Bangxin Zhang 	 
	 	Name:  	ZHANG Bangxin () 	 
	 	 	 	 
	 
	 	CENTRAL GLORY INVESTMENTS LIMITED

 	 
	 	By:  	/s/
Yundong Cao 	 
	 	Name:  	CAO Yundong () 	 
	 	 	 	 
	 
	 	PERFECT WISDOM INTERNATIONAL LIMITED

 	 
	 	By:  	/s/
Yachao Liu 	 
	 	Name:  	LIU Yachao () 	 
	 	 	 	 
	 
	 	EXCELLENT NEW LIMITED

 	 
	 	By:  	/s/
Yunfeng Bai
 	 
	 	Name:  	BAI Yunfeng () 	 
	 	 	 	 
	 

SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT

 

 

     IN WITNESS WHEREOF, the parties have executed this Shareholder’ Agreement as of the date first
written above.

	 	 	 	 	 
	FOUNDERS	ZHANG Bangxin ()

 	 
	 	By:  	/s/
Bangxin Zhang 	 
	 	Name:  	ZHANG Bangxin 	 
	 	 	 	 
	 
	 	CAO YUNDONG ()

 	 
	 	By:  	/s/
Yundong Cao 	 
	 	Name:  	CAO Yundong 	 
	 	 	 	 
	 
	 	LIU Yachao ()

 	 
	 	By:  	/s/
Yachao Liu 	 
	 	Name:  	LIU Yachao 	 
	 	 	 	 
	 
	 	BAI YUNFENG ()

 	 
	 	By:  	/s/
Yunfeng Bai 	 
	 	Name:  	BAI Yunfeng 	 
	 	 	 	 

 

 

	 	 	 	 	 

     IN WITNESS WHEREOF, the parties have executed this Shareholders’ Agreement as of the date
first written above.

	 	 	 	 	 
	COMPANY:	XUEERSI INTERNATIONAL EDUCATION GROUP

 	 
	 	By:  	/s/
Bangxin Zhang 	 
	 	Name:  	ZHANG Bangxin 	 
	 	Title:  	Director 	 
	 
	 
	HK COMPANY:	TAL GROUP LIMITED

 	 
	 	By:  	/s/
Bangxin Zhang 	 
	 	Name:  	ZHANG Bangxin 	 
	 	Title:  	Director 	 
	 
	 
	WFOE:	TAL EDUCATION TECHNOLOGY (BEIJING) CO., LTD.

 	 
	 	By:  	/s/
Bangxin Zhang 	 
	 	Name:  	ZHANG Bangxin 	 
	 	Title:  	Legal Representative	 
	 	Affix Seal: 	 
	 

SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT

 

 

     IN WITNESS WHEREOF, the parties have executed this Shareholders’ Agreement as of the date
first written above.

	 	 	 	 	 
	DOMESTIC COMPANIES	BEIJING XUEERSI EDUCATION TECHNOLOGY CO., LTD.

 	 
	 	By:  	/s/
Yachao Liu 	 
	 	Name:  	LIU Yachao 	 
	 	Title:  	Legal Representative 	 
	 
	 	Affix Seal: 	 
	 
	 
	 	BEIJING XUEERSI NETWORK TECHNOLOGY CO., LTD.

 	 
	 	By:  	/s/
Yachao Liu 	 
	 	Name:  	LIU Yachao 	 
	 	Title:  	Legal Representative 	 
	 
	 	Affix Seal: 	 
	 

SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT

 

 

     IN WITNESS WHEREOF, the parties have executed this Shareholders’ Agreement as of the date
first written above.

	 	 	 	 	 
	SERIES A PREFERRED SHAREHOLDER:	KTB/UCI China Ventures II Limited

 	 
	 	By:  	/s/
Authorized Signatory 	 
	 	Name:  	 	 
	 	Title:  	Legal Representative 	 
	 
	 	Affix Seal: 	 

SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT

 

 

     IN WITNESS WHEREOF, the parties have executed this Shareholders’ Agreement as of the date
first written above.

	 	 	 	 	 
	TIGER:	Tiger Global Five China Holdings

 	 
	 	By:  	/s/
Authorized Signatory 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 

SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT

 

 

SCHEDULE 1

Particulars of the Company as at the date of this Agreement

	1.	 	Name:          Xueersi International Education Group()
	 
	2.	 	Date of Incorporation:          January 10, 2008
	 
	3.	 	Country of incorporation and status of company:          Cayman Islands, Private company limited by shares

	4.	 	Registered office:	The Registered Office of the Company shall be at the
offices of Offshore Incorporations (Cayman) Limited, Scotia Centre,
4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman
Island.

	5.	 	Authorized share capital:	US$200,000.00, divided into 200,000,000 shares of par value of US$0.001 each, of which 195,000,000 are classified as Common Shares and 5,000,000 shares are designated as Series A Preferred Shares.

	6.	 	Issued or reserved shares:	125,000,000 Common Shares and 5,000,000 Series A Preferred Shares

	7.	 	Directors:          ZHANG Bangxin, CAO Yundong, LIU Yachao, BAI Yunfeng, YEH Aieming Amy
	 
	8.	 	Secretary:          CIA Nominee Holdings Limited
	 
	9.	 	Financial year end:          the last day of February

Schedule 1exv10w1

Exhibit 10.1

TAL EDUCATION GROUP

2010 SHARE INCENTIVE PLAN

ARTICLE 1

PURPOSE

     The purpose of this TAL Education Group 2010 Share Incentive Plan (the “Plan”) is to
promote the success and enhance the value of TAL Education Group, a company formed under the laws
of the Cayman Islands (the “Company”) by aligning the personal interests of the members of
the Board, Employees, and Consultants to those of the Company’s shareholders and by providing such
individuals with an incentive for outstanding performance. The Plan is further intended to provide
flexibility to the Company in its ability to motivate, attract, and retain the services of members
of the Board, Employees, and Consultants upon whose judgment and contribution the Company’s
business is largely dependent.

ARTICLE 2

DEFINITIONS AND CONSTRUCTION

     Wherever the following terms are used in the Plan they shall have the meanings specified
below, unless the context clearly indicates otherwise. The singular pronoun shall include the
plural where the context so indicates.

     2.1 “Applicable Laws” means the legal requirements relating to the Plan and the
Awards under applicable provisions of the corporate, securities, tax and other laws, rules,
regulations and government orders, and the rules of any applicable stock exchange or national
market system, of any jurisdiction applicable to Awards granted to residents therein.

     2.2 “Award” means an Option, Restricted Share or Restricted Share Unit award granted
to a Participant pursuant to the Plan.

     2.3 “Award Agreement” means any written agreement, contract, or other instrument or
document evidencing an Award, including through electronic medium.

     2.4 “Board” means the Board of Directors of the Company.

     2.5 “Code” means the Internal Revenue Code of 1986 of the United States, as amended.

     2.6 “Committee” means a committee of the Board described in Article 10.

     2.7 “Consultant” means any consultant or adviser if: (a) the consultant or adviser
renders bona fide services to a Service Recipient; (b) the services rendered by the consultant or
adviser are not in connection with the offer or sale of securities in a capital-raising

 

 

transaction and do not directly or indirectly promote or maintain a market for the Company’s
securities; and (c) the consultant or adviser is a natural person who has contracted directly
with the Service Recipient to render such services.

     2.8 “Corporate Transaction”, unless otherwise defined in an Award Agreement, means
any of the following transactions, provided, however, that the Committee shall determine under
(d) and (e) whether multiple transactions are related, and its determination shall be final,
binding and conclusive:

               (a) an amalgamation, arrangement or consolidation or scheme of arrangement (i) in which the
Company is not the surviving entity, except for a transaction the principal purpose of which is to
change the jurisdiction in which the Company is incorporated or (ii) following which the holders of
the voting securities of the Company do not continue to hold more than 50% of the combined voting
power of the voting securities of the surviving entity;

               (b) the sale, transfer or other disposition of all or substantially all of the assets of the
Company;

               (c) the complete liquidation or dissolution of the Company;

               (d) any reverse takeover or series of related transactions culminating in a reverse takeover
(including, but not limited to, a tender offer followed by a reverse takeover) in which the Company
is the surviving entity but (A) the Company’s equity securities outstanding immediately prior to
such takeover are converted or exchanged by virtue of the takeover into other property, whether in
the form of securities, cash or otherwise, or (B) in which securities possessing more than fifty
percent (50%) of the total combined voting power of the Company’s outstanding securities are
transferred to a person or persons different from those who held such securities immediately prior
to such takeover or the initial transaction culminating in such takeover, but excluding any such
transaction or series of related transactions that the Committee determines shall not be a
Corporate Transaction; or

               (e) acquisition in a single or series of related transactions by any person or related group
of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial
ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than
fifty percent (50%) of the total combined voting power of the Company’s outstanding securities but
excluding any such transaction or series of related transactions that the Committee determines
shall not be a Corporate Transaction.

     2.9 “Disability”, unless otherwise defined in an Award Agreement, means that the
Participant qualifies to receive long-term disability payments under the Service Recipient’s
long-term disability insurance program, as it may be amended from time to time, to which the
Participant provides services regardless of whether the Participant is covered by such policy.
If the Service Recipient to which the Participant provides service does not have a long-term
disability plan in place, “Disability” means that a Participant is unable to carry out the
responsibilities and functions of the position held by the Participant by reason of any
medically determinable physical or mental impairment for a period of not less than ninety
(90) consecutive days. A Participant will not be considered to have incurred a Disability unless

2

 

he or she furnishes proof of such impairment sufficient to satisfy the Committee in its
discretion.

     2.10 “Effective Date” shall have the meaning set forth in Section 11.1.

     2.11 “Employee” means any person, including an officer or a member of the Board of
the Company or any Parent or Subsidiary of the Company, who is in the employment of a Service
Recipient, subject to the control and direction of the Service Recipient as to both the work to
be performed and the manner and method of performance. The payment of a director’s fee by a
Service Recipient shall not be sufficient to constitute “employment” by the Service Recipient.

     2.12 “Exchange Act” means the Securities Exchange Act of 1934 of the United States,
as amended.

     2.13 “Fair Market Value” means, as of any date, the value of Shares determined as
follows:

               (a) If the Shares are listed on one or more established stock exchanges or national market
systems, including without limitation, The New York Stock Exchange and The Nasdaq Stock Market, its
Fair Market Value shall be the closing sales price for such Shares (or the closing bid, if no sales
were reported) as quoted on the principal exchange or system on which the Shares are listed (as
determined by the Committee) on the date of determination (or, if no closing sales price or closing
bid was reported on that date, as applicable, on the last trading date such closing sales price or
closing bid was reported), as reported in The Wall Street Journal or such other source as the
Committee deems reliable;

               (b) If the Shares are regularly quoted on an automated quotation system (including the OTC
Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing
sales price for such Shares as quoted on such system or by such securities dealer on the date of
determination, but if selling prices are not reported, the Fair Market Value of a Share shall be
the mean between the high bid and low asked prices for the Shares on the date of determination (or,
if no such prices were reported on that date, on the last date such prices were reported), as
reported in The Wall Street Journal or such other source as the Committee deems reliable; or

               (c) In the absence of an established market for the Shares of the type described in (a) and
(b), above, the Fair Market Value thereof shall be determined by the Committee in good faith and in
its discretion by reference to (i) the placing price of the latest private placement of the Shares
and the development of the Company’s business operations and the general economic and market
conditions since such latest private placement, (ii) other third party transactions involving the
Shares and the development of the Company’s business operation and the general economic and market
conditions since such sale, (iii) an independent valuation of the Shares, or (iv) such other methodologies or information as the Committee
determines to be indicative of Fair Market Value.

3

 

     2.14 “Incentive Share Option” means an Option that is intended to meet the
requirements of Section 422 of the Code or any successor provision thereto.

     2.15 “Independent Director” means a member of the Board who is a non-Employee
Director and who meets the independent standards under the stock exchange on which the Company’s
Shares are listed, if applicable.

     2.16 “Non-Employee Director” means a member of the Board who qualifies as a
“Non-Employee Director” as defined in Rule 16b-3(b)(3) of the Exchange Act, or any successor
definition adopted by the Board.

     2.17 “Non-Qualified Share Option” means an Option that is not intended to be an
Incentive Share Option.

     2.18 “Option” means a right granted to a Participant pursuant to Article 5 of the
Plan to purchase a specified number of Shares at a specified price during specified time periods.
An Option may be either an Incentive Share Option or a Non-Qualified Share Option.

     2.19 “Participant” means a person who, as a member of the Board, Consultant or
Employee, has been granted an Award pursuant to the Plan.

     2.20 “Parent” means a parent corporation under Section 424(e) of the Code.

     2.21 “Plan” means this TAL Education Group 2010 Share Incentive Plan, as it may be
amended from time to time.

     2.22 “Related Entity” means any business, corporation, partnership, limited
liability company or other entity in which the Company, a Parent or Subsidiary of the Company
holds a substantial ownership interest, directly or indirectly, but which is not a Subsidiary and
which the Board designates as a Related Entity for purposes of the Plan.

     2.23 “Restricted Share” means a Share awarded to a Participant pursuant to Article 6
that is subject to certain restrictions and may be subject to risk of forfeiture.

     2.24 “Restricted Share Unit” means the right granted to a Participant pursuant to
Article 7 to receive a Share at a future date.

     2.25 “Securities Act” means the Securities Act of 1933 of the United States, as
amended.

     2.26 “Service Recipient” means the Company, any Parent or Subsidiary of the Company
and any Related Entity to which a Participant provides services as an Employee, a Consultant or a
Director.

     2.27 “Share” means ordinary shares of the Company, and such other securities of the
Company that may be substituted for Shares pursuant to Article 9.

4

 

     2.28 “Subsidiary” means any corporation or other entity of which a majority of the
outstanding voting shares or voting power is beneficially owned directly or indirectly by the
Company.

     2.29 “Trading Date” means the closing of the first sale to the general public of the
Shares pursuant to a registration statement filed with and declared effective by the U.S.
Securities and Exchange Commission under the Securities Act.

ARTICLE 3

SHARES SUBJECT TO THE PLAN

     3.1 Number of Shares.

               (a) Subject to the provisions of Article 9 and Section 3.1(b), the maximum aggregate number of
Shares which may be issued pursuant to all Awards (including Incentive Share Options) shall be
18,750,000.

               (b) To the extent that an Award terminates, expires, or lapses for any reason, any Shares
subject to the Award shall again be available for the grant of an Award pursuant to the Plan. To
the extent permitted by Applicable Laws, Shares issued in assumption of, or in substitution for,
any outstanding awards of any entity acquired in any form or combination by the Company or any
Parent or Subsidiary of the Company shall not be counted against Shares available for grant
pursuant to the Plan. Shares delivered by the Participant or withheld by the Company upon the
exercise of any Award under the Plan, in payment of the exercise price thereof or tax withholding
thereon, may again be optioned, granted or awarded hereunder, subject to the limitations of Section
3.1(a). If any Restricted Shares are forfeited by the Participant or repurchased by the Company,
such Shares may again be optioned, granted or awarded hereunder, subject to the limitations of
Section 3.1(a). Notwithstanding the provisions of this Section 3.1(b), no Shares may again be
optioned, granted or awarded if such action would cause an Incentive Share Option to fail to
qualify as an incentive Share option under Section 422 of the Code.

     3.2 Shares Distributed. Any Shares distributed pursuant to an Award may consist, in
whole or in part, of authorized and unissued Shares, treasury shares (subject to Applicable Laws)
or Shares purchased on the open market. Additionally, in the discretion of the Committee,
American Depository Shares in an amount equal to the number of Shares which otherwise would be
distributed pursuant to an Award may be distributed in lieu of Shares in settlement of any Award.
If the number of Shares represented by an American Depository Share is other than on a
one-to-one basis, the limitations of Section 3.1 shall be adjusted to reflect the distribution of
American Depository Shares in lieu of Shares.

ARTICLE 4

ELIGIBILITY AND PARTICIPATION

     4.1 Eligibility. Persons eligible to participate in this Plan include Employees,

5

 

Consultants, and all members of the Board, as determined by the Committee.

     4.2 Participation. Subject to the provisions of the Plan, the Committee may, from
time to time, select from among all eligible individuals, those to whom Awards shall be granted
and shall determine the nature and amount of each Award. No individual shall have any right to
be granted an Award pursuant to this Plan.

     4.3 Jurisdictions. In order to assure the viability of Awards granted to
Participants employed in various jurisdictions, the Committee may provide for such special terms
as it may consider necessary or appropriate to accommodate differences in local law, tax policy,
or custom applicable in the jurisdiction in which the Participant resides or is employed.
Moreover, the Committee may approve such supplements to, or amendments, restatements, or
alternative versions of, the Plan as it may consider necessary or appropriate for such purposes
without thereby affecting the terms of the Plan as in effect for any other purpose; provided,
however, that no such supplements, amendments, restatements, or alternative versions shall
increase the share limitations contained in Section 3.1 of the Plan. Notwithstanding the
foregoing, the Committee may not take any actions hereunder, and no Awards shall be granted, that
would violate any Applicable Laws.

ARTICLE 5

OPTIONS

     5.1 General. The Committee is authorized to grant Options to Participants on the
following terms and conditions:

               (a) Exercise Price. The exercise price per Share subject to an Option shall be
determined by the Committee and set forth in the Share Option Award Agreement which may be a fixed
or variable price related to the Fair Market Value of the Shares. The exercise price per Share
subject to an Option may be amended or adjusted in the absolute discretion of the Committee, the
determination of which shall be final, binding and conclusive. For the avoidance of doubt, to the
extent not prohibited by Applicable Laws or any exchange rule, a downward adjustment of the
exercise prices of Options mentioned in the preceding sentence shall be effective without the
approval of the Company’s shareholders or the approval of the affected Participants.

               (b) Time and Conditions of Exercise. The Committee shall determine the time or times
at which an Option may be exercised in whole or in part, including exercise prior to vesting;
provided that the term of any Option granted under the Plan shall not exceed ten years, except as provided in Section 12.1. The Committee shall also determine any conditions,
if any, that must be satisfied before all or part of an Option may be exercised.

               (c) Payment. The Committee shall determine the methods by which the exercise price of
an Option may be paid, the form of payment, including, without limitation (i) cash or check
denominated in U.S. Dollars, (ii) to the extent permissible under the Applicable Laws, cash or
check in Chinese Renminbi, (iii) cash or check denominated in any other local currency as approved
by the Committee, (iv) Shares held for such period of time as may be

6

 

required by the Committee in
order to avoid adverse financial accounting consequences and having a Fair Market Value on the date
of delivery equal to the exercise price, (v) after the Trading Date, the delivery of a notice that
the Participant has placed a market sell order with a broker with respect to Shares then issuable
upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of
the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided
that payment of such proceeds is then made to the Company upon settlement of such sale, (vi) other
property acceptable to the Committee with a Fair Market Value equal to the exercise price, or (vii)
any combination of the foregoing. Notwithstanding any other provision of the Plan to the contrary,
no Participant who is a member of the Board or an “executive officer” of the Company within the
meaning of Section 13(k) of the Exchange Act shall be permitted to pay the exercise price of an
Option in any method which would violate Section 13(k) of the Exchange Act.

               (d) Evidence of Grant. All Options shall be evidenced by an Award Agreement between
the Company and the Participant. The Award Agreement shall include such additional provisions as
may be specified by the Committee.

     5.2 Incentive Share Options. Incentive Share Options may be granted to Employees of
the Company, a Parent or Subsidiary of the Company. Incentive Share Options may not be granted
to Employees of a Related Entity or to Independent Directors or Consultants. The terms of any
Incentive Share Options granted pursuant to the Plan, in addition to the requirements of Section
5.1, must comply with the following additional provisions of this Section 5.2:

               (a) Expiration of Option. An Incentive Share Option may not be exercised to any
extent by anyone after the first to occur of the following events:

                    (i) Ten years from the date it is granted, unless an earlier time is set in the Award
Agreement;

                    (ii) [60 days] after the Participant’s termination of employment as an Employee; and

                    (iii) [Six months] after the date of the Participant’s termination of employment or service on
account of Disability or death. Upon the Participant’s Disability or death, any Incentive Share
Options exercisable at the Participant’s Disability or death may be exercised by the Participant’s
legal representative or representatives, by the person or persons entitled to do so pursuant to the Participant’s last will and testament, or, if the
Participant fails to make testamentary disposition of such Incentive Share Option or dies
intestate, by the person or persons entitled to receive the Incentive Share Option pursuant to the
applicable laws of descent and distribution.

               (b) Individual Dollar Limitation. The aggregate Fair Market Value (determined as of
the time the Option is granted) of all Shares with respect to which Incentive Share Options are
first exercisable by a Participant in any calendar year may not exceed $100,000 or such other
limitation as imposed by Section 422(d) of the Code, or any successor provision. To the extent
that Incentive Share Options are first exercisable by a Participant in

7

 

excess of such limitation,
the excess shall be considered Non-Qualified Share Options.

               (c) Exercise Price. The exercise price of an Incentive Share Option shall be equal to
the Fair Market Value on the date of grant. However, the exercise price of any Incentive Share
Option granted to any individual who, at the date of grant, owns Shares possessing more than ten
percent of the total combined voting power of all classes of Shares of the Company may not be less
than 110% of Fair Market Value on the date of grant and such Option may not be exercisable for more
than five years from the date of grant.

               (d) Transfer Restriction. The Participant shall give the Company prompt notice of any
disposition of Shares acquired by exercise of an Incentive Share Option within (i) two years from
the date of grant of such Incentive Share Option or (ii) one year after the transfer of such Shares
to the Participant.

               (e) Expiration of Incentive Share Options. No Award of an Incentive Share Option may
be made pursuant to this Plan after the tenth anniversary of the Effective Date.

               (f) Right to Exercise. During a Participant’s lifetime, an Incentive Share Option may
be exercised only by the Participant.

ARTICLE 6

RESTRICTED SHARES

     6.1 Grant of Restricted Shares. The Committee, at any time and from time to time,
may grant Restricted Shares to Participants as the Committee, in its sole discretion, shall
determine. The Committee, in its sole discretion, shall determine the number of Restricted
Shares to be granted to each Participant.

     6.2 Restricted Shares Award Agreement. Each Award of Restricted Shares shall be
evidenced by a Restricted Shares Award Agreement that shall specify the period of restriction,
the number of Restricted Shares granted, and such other terms and conditions as the Committee, in
its sole discretion, shall determine. Unless the Committee determines otherwise, Restricted
Shares shall be held by the Company as escrow agent until the restrictions on such Restricted
Shares have lapsed.

     6.3 Issuance and Restrictions. Restricted Shares shall be subject to such
restrictions on transferability and other restrictions as the Committee may impose (including,
without limitation, limitations on the right to vote Restricted Shares or the right to receive
dividends on the Restricted Share). These restrictions may lapse separately or in combination at
such times, pursuant to such circumstances, in such installments, or otherwise, as the Committee
determines at the time of the grant of the Award or thereafter.

     6.4 Forfeiture/Repurchase. Except as otherwise determined by the Committee at the
time of the grant of the Award or thereafter, upon termination of employment or service during
the applicable restriction period, Restricted Shares that are at that time subject to
restrictions shall be forfeited or repurchased in accordance with the Restricted Shares Award

8

 

Agreement; provided, however, the Committee may (a) provide in any Restricted Shares Award
Agreement that restrictions or forfeiture and repurchase conditions relating to Restricted Shares
will be waived in whole or in part in the event of terminations resulting from specified causes,
and (b) in other cases waive in whole or in part restrictions or forfeiture and repurchase
conditions relating to Restricted Shares.

     6.5 Certificates for Restricted Shares. Restricted Shares granted pursuant to the
Plan may be evidenced in such manner as the Committee shall determine. If certificates
representing Restricted Shares are registered in the name of the Participant, certificates must
bear an appropriate legend referring to the terms, conditions, and restrictions applicable to
such Restricted Shares, and the Company may, at its discretion, retain physical possession of the
certificate until such time as all applicable restrictions lapse.

     6.6 Removal of Restrictions. Except as otherwise provided in this Article 6,
Restricted Shares granted under the Plan shall be released from escrow as soon as practicable
after the last day of the period of restriction. The Committee, in its discretion, may
accelerate the time at which any restrictions shall lapse or be removed. After the restrictions
have lapsed, the Participant shall be entitled to have any legend or legends under Section 6.5
removed from his or her Share certificate, and the Shares shall be freely transferable by the
Participant, subject to applicable legal restrictions. The Committee (in its discretion) may
establish procedures regarding the release of Shares from escrow and the removal of legends, as
necessary or appropriate to minimize administrative burdens on the Company.

ARTICLE 7

RESTRICTED SHARE UNITS

     7.1 Grant of Restricted Share Units. The Committee, at any time and from time to
time, may grant Restricted Share Units to Participants as the Committee, in its sole discretion,
shall determine. The Committee, in its sole discretion, shall determine the number of Restricted
Share Units to be granted to each Participant.

     7.2 Restricted Share Units Award Agreement. Each Award of Restricted Share Units
shall be evidenced by a Restricted Share Units Award Agreement that shall specify any vesting conditions, the number of Restricted Share Units granted, and such other terms and
conditions as the Committee, in its sole discretion, shall determine.

     7.3 Performance Objectives and Other Terms. The Committee, in its discretion, shall
set performance objectives or other vesting criteria which, depending on the extent to which they
are met, will determine the number or value of Restricted Share Units that will be paid out to
the Participants.

     7.4 Form and Timing of Payment of Restricted Share Units. At the time of grant, the
Committee shall specify the date or dates on which the Restricted Share Units shall become fully
vested and nonforfeitable. Upon vesting, the Committee, in its sole discretion, may pay
Restricted Share Units in the form of cash, in Shares or in a combination thereof.

9

 

     7.5 Forfeiture/Repurchase. Except as otherwise determined by the Committee at the
time of the grant of the Award or thereafter, upon termination of employment or service during
the applicable restriction period, Restricted Share Units that are at that time unvested shall be
forfeited or repurchased in accordance with the Restricted Share Units Award Agreement; provided,
however, the Committee may (a) provide in any Restricted Share Units Award Agreement that
restrictions or forfeiture and repurchase conditions relating to Restricted Share Units will be
waived in whole or in part in the event of terminations resulting from specified causes, and (b)
in other cases waive in whole or in part restrictions or forfeiture and repurchase conditions
relating to Restricted Share Units.

ARTICLE 8

PROVISIONS APPLICABLE TO AWARDS

     8.1 Award Agreement. Awards under the Plan shall be evidenced by Award Agreements
that set forth the terms, conditions and limitations for each Award which may include the term of
an Award, the provisions applicable in the event the Participant’s employment or service
terminates, and the Company’s authority to unilaterally or bilaterally amend, modify, suspend,
cancel or rescind an Award.

     8.2 Limits on Transfer. No right or interest of a Participant in any Award may be
pledged, encumbered, or hypothecated to or in favor of any party other than the Company or a
Subsidiary, or shall be subject to any lien, obligation, or liability of such Participant to any
other party other than the Company or a Subsidiary. Except as otherwise provided by the
Committee, no Award shall be assigned, transferred, or otherwise disposed of by a Participant
other than by will or the laws of descent and distribution. The Committee by express provision
in the Award or an amendment thereto may permit an Award (other than an Incentive Share Option)
to be transferred to, exercised by and paid to certain persons or entities related to the
Participant, including but not limited to members of the Participant’s family, charitable
institutions, or trusts or other entities whose beneficiaries or beneficial owners are members of
the Participant’s family and/or charitable institutions, or to such other persons or entities as
may be expressly approved by the Committee, pursuant to such conditions and procedures as the Committee may establish. Any permitted transfer shall be
subject to the condition that the Committee receive evidence satisfactory to it that the transfer
is being made for estate and/or tax planning purposes (or to a “blind trust” in connection with
the Participant’s termination of employment or service with the Company or a Subsidiary to assume
a position with a governmental, charitable, educational or similar non-profit institution) and on
a basis consistent with the Company’s lawful issue of securities.

     8.3 Beneficiaries. Notwithstanding Section 8.2, a Participant may, in the manner
determined by the Committee, designate a beneficiary to exercise the rights of the Participant
and to receive any distribution with respect to any Award upon the Participant’s death. A
beneficiary, legal guardian, legal representative, or other person claiming any rights pursuant
to the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable
to the Participant, except to the extent the Plan and Award Agreement otherwise provide, and to
any additional restrictions deemed necessary or appropriate by the Committee. If the Participant
is married and resides in a community property state, a designation of a

10

 

person other than the
Participant’s spouse as his or her beneficiary with respect to more than 50% of the Participant’s
interest in the Award shall not be effective without the prior written consent of the
Participant’s spouse. If no beneficiary has been designated or survives the Participant, payment
shall be made to the person entitled thereto pursuant to the Participant’s will or the laws of
descent and distribution. Subject to the foregoing, a beneficiary designation may be changed or
revoked by a Participant at any time provided the change or revocation is filed with the
Committee.

     8.4 Share Certificates. Notwithstanding anything herein to the contrary, the
Company shall not be required to issue or deliver any certificates evidencing Shares pursuant to
the exercise of any Award, unless and until the Committee has determined, with advice of counsel,
that the issuance and delivery of such certificates is in compliance with all Applicable Laws,
regulations of governmental authorities and, if applicable, the requirements of any exchange on
which the Shares are listed or traded. All Share certificates delivered pursuant to the Plan are
subject to any stop-transfer orders and other restrictions as the Committee deems necessary or
advisable to comply with all Applicable Laws, and the rules of any national securities exchange
or automated quotation system on which the Shares are listed, quoted, or traded. The Committee
may place legends on any Share certificate to reference restrictions applicable to the Shares.
In addition to the terms and conditions provided herein, the Committee may require that a
Participant make such reasonable covenants, agreements, and representations as the Committee, in
its discretion, deems advisable in order to comply with any such laws, regulations, or
requirements. The Committee shall have the right to require any Participant to comply with any
timing or other restrictions with respect to the settlement or exercise of any Award, including a
window-period limitation, as may be imposed in the discretion of the Committee.

     8.5 Paperless Administration. Subject to Applicable Laws, the Committee may make
Awards, provide applicable disclosure and procedures for exercise of Awards by an internet
website or interactive voice response system for the paperless administration of Awards.

     8.6 Foreign Currency. A Participant may be required to provide evidence that any
currency used to pay the exercise price of any Award were acquired and taken out of the
jurisdiction in which the Participant resides in accordance with Applicable Laws, including
foreign exchange control laws and regulations. In the event the exercise price for an Award is
paid in Chinese Renminbi or other foreign currency, as permitted by the Committee, the amount
payable will be determined by conversion from U.S. dollars at the official rate promulgated by
the People’s Bank of China for Chinese Renminbi, or for jurisdictions other than the People’s
Republic of China, the exchange rate as selected by the Committee on the date of exercise.

ARTICLE 9

CHANGES IN CAPITAL STRUCTURE

     9.1 Adjustments. In the event of any dividend, share split, combination or exchange
of Shares, amalgamation, arrangement or consolidation, spin-off, recapitalization or other

11

 

distribution (other than normal cash dividends) of Company assets to its shareholders, or any
other change affecting Shares or the price of a Share, the Committee shall make such
proportionate adjustments, if any, as the Committee in its discretion may deem appropriate to
reflect such change with respect to (a) the aggregate number and type of Shares that may be
issued under the Plan (including, but not limited to, adjustments of the limitations in Section
3.1); (b) the terms and conditions of any outstanding Awards (including, without limitation, any
applicable performance targets or criteria with respect thereto); and (c) the grant or exercise
price per Share for any outstanding Awards under the Plan.

     9.2 Corporate Transactions. Except as may otherwise be provided in any Award
Agreement or any other written agreement entered into by and between the Company and a
Participant, if the Committee anticipates the occurrence, or upon the occurrence, of a Corporate
Transaction, the Committee may, in its sole discretion, provide for (i) any and all Awards
outstanding hereunder to terminate at a specific time in the future and shall give each
Participant the right to exercise the vested portion of such Awards during a period of time as
the Committee shall determine, or (ii) the purchase of any Award for an amount of cash equal to
the amount that could have been attained upon the exercise of such Award (and, for the avoidance
of doubt, if as of such date the Committee determines in good faith that no amount would have
been attained upon the exercise of such Award, then such Award may be terminated by the Company
without payment), or (iii) the replacement of such Award with other rights or property selected
by the Committee in its sole discretion or the assumption of or substitution of such Award by the
successor or surviving corporation, or a Parent or Subsidiary thereof, with appropriate
adjustments as to the number and kind of Shares and prices, or (iv) payment of an Award in cash
based on the value of Shares on the date of the Corporate Transaction plus reasonable interest on
the Award through the date when such Award would otherwise be vested or have been paid in
accordance with its original terms, if necessary to comply with Section 409A of the Code.

     9.3 Outstanding Awards—Other Changes. In the event of any other change in the
capitalization of the Company or corporate change other than those specifically referred to in
this Article 9, the Committee may, in its absolute discretion, make such adjustments in the
number and class of Shares subject to Awards outstanding on the date on which such change occurs
and in the per Share grant or exercise price of each Award as the Committee may consider
appropriate to prevent dilution or enlargement of rights.

     9.4 No Other Rights. Except as expressly provided in the Plan, no Participant shall
have any rights by reason of any subdivision or consolidation of Shares of any class, the payment
of any dividend, any increase or decrease in the number of Shares of any class or any
dissolution, liquidation, merger, or consolidation of the Company or any other corporation.
Except as expressly provided in the Plan or pursuant to action of the Committee under the Plan,
no issuance by the Company of Shares of any class, or securities convertible into Shares of any
class, shall affect, and no adjustment by reason thereof shall be made with respect to, the
number of Shares subject to an Award or the grant or exercise price of any Award.

12

 

ARTICLE 10

ADMINISTRATION

     10.1 Committee. The Plan shall be administered by the Board or a committee of one
or more members of the Board (the “Committee”) to whom the Board shall delegate the authority to
grant or amend Awards to Participants other than any of the Committee members. Any grant or
amendment of Awards to any Committee member shall then require an affirmative vote of a majority
of the Board members who are not on the Committee.

     10.2 Action by the Committee. A majority of the Committee shall constitute a
quorum. The acts of a majority of the members present at any meeting at which a quorum is
present, and acts approved in writing by a majority of the Committee in lieu of a meeting, shall
be deemed the acts of the Committee. Each member of the Committee is entitled to, in good faith,
rely or act upon any report or other information furnished to that member by any officer or other
employee of the Company or any Subsidiary, the Company’s independent certified public
accountants, or any executive compensation consultant or other professional retained by the
Company to assist in the administration of the Plan.

     10.3 Authority of Committee. Subject to any specific designation in the Plan, the
Committee has the exclusive power, authority and discretion to:

               (a) Designate Participants to receive Awards;

               (b) Determine the type or types of Awards to be granted to each Participant;

               (c) Determine the number of Awards to be granted and the number of Shares to which an Award
will relate;

               (d) Determine the terms and conditions of any Award granted pursuant to the Plan, including, but not limited to, the exercise price, grant price, or purchase price, any
restrictions or limitations on the Award, any schedule for lapse of forfeiture restrictions or
restrictions on the exercisability of an Award, and accelerations or waivers thereof, any
provisions related to non-competition and recapture of gain on an Award, based in each case on such
considerations as the Committee in its sole discretion determines;

               (e) Determine whether, to what extent, and pursuant to what circumstances an Award may be
settled in, or the exercise price of an Award may be paid in, cash, Shares, other Awards, or other
property, or an Award may be canceled, forfeited, or surrendered;

               (f) Prescribe the form of each Award Agreement, which need not be identical for each
Participant;

               (g) Decide all other matters that must be determined in connection with an Award;

               (h) Establish, adopt, or revise any rules and regulations as it may deem necessary or
advisable to administer the Plan;

               (i) Interpret the terms of, and any matter arising pursuant to, the Plan or any Award
Agreement; and

13

 

               (j) Make all other decisions and determinations that may be required pursuant to the Plan or
as the Committee deems necessary or advisable to administer the Plan.

     10.4 Decisions Binding. The Committee’s interpretation of the Plan, any Awards
granted pursuant to the Plan, any Award Agreement and all decisions and determinations by the
Committee with respect to the Plan are final, binding, and conclusive on all parties.

ARTICLE 11

EFFECTIVE AND EXPIRATION DATE

     11.1 Effective Date. The Plan is effective as of the date the Plan is adopted and
approved by the Board (the “Effective Date”). The Plan will be deemed to be approved by
the shareholders if it receives the affirmative vote of the holders of a majority of the share
capital of the Company present or represented and entitled to vote at a meeting duly held in
accordance with the applicable provisions of the Company’s Memorandum of Association and Articles
of Association.

     11.2 Expiration Date. The Plan will expire on, and no Award may be granted pursuant
to the Plan after, the tenth anniversary of the Effective Date. Any Awards that are outstanding
on the tenth anniversary of the Effective Date shall remain in force according to the terms of
the Plan and the applicable Award Agreement.

ARTICLE 12

AMENDMENT, MODIFICATION, AND TERMINATION

     12.1 Amendment, Modification, And Termination. With the approval of the Board, at
any time and from time to time, the Committee may terminate, amend or modify the Plan; provided,
however, that (a) to the extent necessary and desirable to comply with Applicable Laws, or stock
exchange rules, the Company shall obtain shareholder approval of any Plan amendment in such a
manner and to such a degree as required, unless the Company decides to follow home country
practice, and (b) unless the Company decides to follow home country practice, shareholder
approval is required for any amendment to the Plan that (i) increases the number of Shares
available under the Plan (other than any adjustment as provided by Article 9), (ii) permits the
Committee to extend the term of the Plan or the exercise period for an Option beyond ten years
from the date of grant, or (iii) results in a material increase in benefits or a change in
eligibility requirements.

     12.2 Awards Previously Granted. Except with respect to amendments made pursuant to
Section 12.1, no termination, amendment, or modification of the Plan shall adversely affect in
any material way any Award previously granted pursuant to the Plan without the prior written
consent of the Participant.

14

 

ARTICLE 13

GENERAL PROVISIONS

     13.1 No Rights to Awards. No Participant or other person shall have any claim to be
granted any Award pursuant to the Plan, and neither the Company nor the Committee is obligated to
treat Participants and other persons uniformly.

     13.2 No Shareholders Rights. No Award gives the Participant any of the rights of a
Shareholder of the Company unless and until Shares are in fact issued to such person in
connection with such Award.

     13.3 Taxes. No Shares shall be delivered under the Plan to any Participant until
such Participant has made arrangements acceptable to the Committee for the satisfaction of any
income and employment tax withholding obligations under Applicable Laws. The Company or any
Subsidiary shall have the authority and the right to deduct or withhold, or require a Participant
to remit to the Company, an amount sufficient to satisfy all applicable taxes (including the
Participant’s payroll tax obligations) required or permitted by law to be withheld with respect
to any taxable event concerning a Participant arising as a result of this Plan. The Committee
may in its discretion and in satisfaction of the foregoing requirement allow a Participant to
elect to have the Company withhold Shares otherwise issuable under an Award (or allow the return
of Shares) having a Fair Market Value equal to the sums required to be withheld. Notwithstanding
any other provision of the Plan, the number of Shares which may be withheld with respect to the
issuance, vesting, exercise or payment of any Award (or which may be repurchased from the Participant of such Award after such Shares were
acquired by the Participant from the Company) in order to satisfy any income and payroll tax
liabilities applicable to the Participant with respect to the issuance, vesting, exercise or
payment of the Award shall, unless specifically approved by the Committee, be limited to the
number of Shares which have a Fair Market Value on the date of withholding or repurchase equal to
the aggregate amount of such liabilities based on the minimum statutory withholding rates for the
applicable income and payroll tax purposes that are applicable to such supplemental taxable
income.

     13.4 No Right to Employment or Services. Nothing in the Plan or any Award Agreement
shall interfere with or limit in any way the right of the Service Recipient to terminate any
Participant’s employment or services at any time, nor confer upon any Participant any right to
continue in the employ or service of any Service Recipient.

     13.5 Unfunded Status of Awards. The Plan is intended to be an “unfunded” plan for
incentive compensation. With respect to any payments not yet made to a Participant pursuant to
an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any
rights that are greater than those of a general creditor of the Company or any Subsidiary.

     13.6 Indemnification. To the extent allowable pursuant to applicable law, each
member of the Committee or of the Board shall be indemnified and held harmless by the Company
from any loss, cost, liability, or expense that may be imposed upon or reasonably

15

 

incurred by
such member in connection with or resulting from any claim, action, suit, or proceeding to which
he or she may be a party or in which he or she may be involved by reason of any action or failure
to act pursuant to the Plan and against and from any and all amounts paid by him or her in
satisfaction of judgment in such action, suit, or proceeding against him or her; provided he or
she gives the Company an opportunity, at its own expense, to handle and defend the same before he
or she undertakes to handle and defend it on his or her own behalf. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to which such
persons may be entitled pursuant to the Company’s Memorandum of Association and Articles of
Association, as a matter of law, or otherwise, or any power that the Company may have to
indemnify them or hold them harmless.

     13.7 Relationship to Other Benefits. No payment pursuant to the Plan shall be taken
into account in determining any benefits pursuant to any pension, retirement, savings, profit
sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except
to the extent otherwise expressly provided in writing in such other plan or an agreement
thereunder.

     13.8 Expenses. The expenses of administering the Plan shall be borne by the Company
and its Subsidiaries.

     13.9 Titles and Headings. The titles and headings of the Sections in the Plan are
for convenience of reference only and, in the event of any conflict, the text of the Plan, rather
than such titles or headings, shall control.

     13.10 Fractional Shares. No fractional Shares shall be issued and the Committee
shall determine, in its discretion, whether cash shall be given in lieu of fractional Shares or
whether such fractional Shares shall be eliminated by rounding up or down as appropriate.

     13.11 Limitations Applicable to Section 16 Persons. Notwithstanding any other
provision of the Plan, the Plan, and any Award granted or awarded to any Participant who is then
subject to Section 16 of the Exchange Act, shall be subject to any additional limitations set
forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any
amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such
exemptive rule. To the extent permitted by the Applicable Laws, the Plan and Awards granted or
awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable
exemptive rule.

     13.12 Government and Other Regulations. The obligation of the Company to make
payment of awards in Share or otherwise shall be subject to all Applicable Laws, and to such
approvals by government agencies as may be required. The Company shall be under no obligation to
register any of the Shares paid pursuant to the Plan under the Securities Act or any other
similar law in any applicable jurisdiction. If the Shares paid pursuant to the Plan may in
certain circumstances be exempt from registration pursuant to the Securities Act or other
Applicable Laws, the Company may restrict the transfer of such Shares in such manner as it deems
advisable to ensure the availability of any such exemption.

     13.13 Governing Law. The Plan and all Award Agreements shall be construed in

16

 

accordance with and governed by the laws of the Cayman Islands.

     13.14 Section 409A. To the extent that the Committee determines that any Award
granted under the Plan is or may become subject to Section 409A of the Code, the Award Agreement
evidencing such Award shall incorporate the terms and conditions required by Section 409A of the
Code. To the extent applicable, the Plan and the Award Agreements shall be interpreted in
accordance with Section 409A of the Code and the U.S. Department of Treasury regulations and
other interpretative guidance issued thereunder, including without limitation any such regulation
or other guidance that may be issued after the Effective Date. Notwithstanding any provision of
the Plan to the contrary, in the event that following the Effective Date the Committee determines
that any Award may be subject to Section 409A of the Code and related Department of Treasury
guidance (including such Department of Treasury guidance as may be issued after the Effective
Date), the Committee may adopt such amendments to the Plan and the applicable Award agreement or
adopt other policies and procedures (including amendments, policies and procedures with
retroactive effect), or take any other actions, that the Committee determines are necessary or
appropriate to (a) exempt the Award from Section 409A of the Code and /or preserve the intended
tax treatment of the benefits provided with respect to the Award, or (b) comply with the
requirements of Section 409A of the Code and related U.S. Department of Treasury guidance.

     13.15 Appendices. The Committee may approve such supplements, amendments or
appendices to the Plan as it may consider necessary or appropriate for purposes of compliance
with applicable laws or otherwise and such supplements, amendments or appendices shall be
considered a part of the Plan; provided, however, that no such supplements shall increase the
share limitation contained in Section 3.1 of the Plan without the approval of the Board.

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}]]